<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cells</journal-id><journal-id journal-id-type="iso-abbrev">Cells</journal-id><journal-id journal-id-type="publisher-id">cells</journal-id><journal-title-group><journal-title>Cells</journal-title></journal-title-group><issn pub-type="epub">2073-4409</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30695997</article-id><article-id pub-id-type="pmc">6406383</article-id><article-id pub-id-type="doi">10.3390/cells8020091</article-id><article-id pub-id-type="publisher-id">cells-08-00091</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Autophagy: Dual Response in the Development of Hepatocellular Carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3437-0339</contrib-id><name><surname>Yazdani</surname><given-names>Hamza O.</given-names></name><xref ref-type="aff" rid="af1-cells-08-00091">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Hai</given-names></name><xref ref-type="aff" rid="af2-cells-08-00091">2</xref></contrib><contrib contrib-type="author"><name><surname>Tsung</surname><given-names>Allan</given-names></name><xref ref-type="aff" rid="af2-cells-08-00091">2</xref><xref rid="c1-cells-08-00091" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-cells-08-00091"><label>1</label>Department of Surgery, University of Pittsburgh, Pittsburg, PA 15213-2582, USA; <email>obaidh3@upmc.edu</email></aff><aff id="af2-cells-08-00091"><label>2</label>Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, N924 Doan Hall, 410 West 10th Ave., Columbus, OH 43210, USA; <email>huang.3900@osu.edu</email></aff><author-notes><corresp id="c1-cells-08-00091"><label>*</label>Correspondence: <email>Allan.Tsung@osumc.edu</email>; Tel.: +1-614-293-8304; Fax: +1-614-293-3465</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2019</year></pub-date><volume>8</volume><issue>2</issue><elocation-id>91</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Autophagy is an evolutionary conserved intracellular mechanism which helps eukaryotic cells in maintaining their metabolic state to afford high-efficiency energy requirements. In the physiology of a normal liver and the pathogenesis of liver diseases, autophagy plays a crucial role. Autophagy has been found to be both upregulated and downregulated in different cancers providing the evidence that autophagy plays a dual role in suppressing and promoting cell survival. Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the major leading cause of cancer mortality worldwide. In light of its high complexity and poor prognosis, it is essential to improve our understanding of autophagy&#x02019;s role in HCC. In this review, we summarize the dual mechanism of autophagy in the development of HCC and elucidate the currently used therapeutic strategies for anti-HCC therapy.</p></abstract><kwd-group><kwd>hepatocellular carcinoma</kwd><kwd>inflammation</kwd><kwd>mitophagy</kwd><kwd>oxidative stress</kwd><kwd>HCC therapy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-cells-08-00091"><title>1. Introduction</title><p>Autophagy (macroautophagy) is the fundamental cellular process in maintaining cell homeostasis by targeting damaged intracellular organelles and misfolded proteins to lysosomal degradation [<xref rid="B1-cells-08-00091" ref-type="bibr">1</xref>]. It is a conserved evolutionary process that takes part in all mammalian cells under basal conditions and generates building block molecules to support essential cellular processes [<xref rid="B2-cells-08-00091" ref-type="bibr">2</xref>]. Autophagy is a multistep process including membrane rearrangement in forming a double-membrane bond structure known as autophagosomes. The vesicle fusion of these autophagosomes with lytic compartments generates autolysosomes where lysosomal enzymatic degradation of contents is recycled and releases nucleotides, fatty acids, and amino acids to refuel the cells with energy to maintain necessary molecular synthesis [<xref rid="B2-cells-08-00091" ref-type="bibr">2</xref>].</p><p>The role of autophagy is complex and differs from organ to organ. An organ such as muscles and the liver requires autophagy to remove excessive protein aggregation, lipid accumulation, and damaged mitochondria to prevent excessive ROS generation leading to oxidative stress [<xref rid="B3-cells-08-00091" ref-type="bibr">3</xref>,<xref rid="B4-cells-08-00091" ref-type="bibr">4</xref>]. Defects in autophagy have shown to contributes in several pathogeneses of human diseases ranging from neurodegenerative and metabolic diseases to cancers [<xref rid="B5-cells-08-00091" ref-type="bibr">5</xref>]. The dysregulation of autophagy has been increasingly indicated to play a role in liver diseases such as alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), hepatosteatosis, hepatomegaly, and primary liver malignancies such as hepatocellular carcinoma (HCC) [<xref rid="B6-cells-08-00091" ref-type="bibr">6</xref>,<xref rid="B7-cells-08-00091" ref-type="bibr">7</xref>].</p><p>Hepatocellular carcinoma is a serious threat towards human health. It is the sixth most malignant cancer worldwide and the fifth most common malignancy in men [<xref rid="B8-cells-08-00091" ref-type="bibr">8</xref>]. Despite recent advances in treatments and surgical resection, the five-year survival rate remains unsatisfactory [<xref rid="B9-cells-08-00091" ref-type="bibr">9</xref>]. The most common identified risk factors for HCC development are the consequences of unresolved oxidative stress, persistent inflammation, viral infections, metabolic dysfunction, liver alcohol disease, and fatty liver disease. Autophagy may serve as a protective mechanism against the initial and persistent liver injury in these disease states but autophagy may also play a significant role in the development and growth of hepatic tumor cells in this inflammatory environment [<xref rid="B10-cells-08-00091" ref-type="bibr">10</xref>,<xref rid="B11-cells-08-00091" ref-type="bibr">11</xref>]. The link between autophagy and cancer has been long proposed. The underlying mechanisms regulating the autophagic response in HCC requires further understanding to develop effective treatment strategies. </p></sec><sec id="sec2-cells-08-00091"><title>2. Role of Autophagy in Normal Liver Homeostasis</title><p>Autophagy is involved in diverse physiology and pathophysiology of the liver. The liver displays a complex metabolism with a variety of functions including protein and lipid synthesis and secretion of bile acid. Increased accumulation of ubiquitin proteins aggregation observed in the liver-specific Atg7 knockout mice suggested a basal function of autophagy in continuous turnover of the cytoplasmic proteins [<xref rid="B12-cells-08-00091" ref-type="bibr">12</xref>,<xref rid="B13-cells-08-00091" ref-type="bibr">13</xref>]. Disturbance in the basal autophagy of the liver can lead to the accumulation of elementary bodies, damaged mitochondria, deformed peroxisomes, and abnormal membrane structures resulting in liver injury. Autophagy can be general and nonselective, involving the degradation of a bulk cytoplasmic portion or organelle-specific degradation. The cell can undergo different forms of autophagy which include xenophagy (degradation of viruses), lipophagy (degradation of lipid droplets), ribophagy (degradation of ribosomes), pexophagy (degradation of peroxisomes), reticulophagy (degradation of ER), and mitophagy (degradation of mitochondria). Of these, mitophagy is one of the most well characterized since hepatocytes contain numerous mitochondria to provide the high energy demand for metabolism. Liver specific autophagy deficient mice provide evidence for swollen mitochondria and increased ROS formation [<xref rid="B14-cells-08-00091" ref-type="bibr">14</xref>]. Liver injury is also associated with mitochondrial membrane permeabilization which can activate a mitochondrial apoptotic pathway regulating BAX and Bad (BCL2 family) mediated cell death [<xref rid="B15-cells-08-00091" ref-type="bibr">15</xref>]. The different forms and role of autophagy in the healthy liver are best described in detail by Takashi U Eno et al. [<xref rid="B16-cells-08-00091" ref-type="bibr">16</xref>].</p><p>Hepatocytes are primarily dependent on autophagy degradation due to its intense metabolism and high energy demand to maintain proper functioning. The defect in any of the forms of autophagy can contribute to severe liver functional damage such as hepatitis, fibrosis, cirrhosis, and HCC development [<xref rid="B17-cells-08-00091" ref-type="bibr">17</xref>,<xref rid="B18-cells-08-00091" ref-type="bibr">18</xref>]. One of the most common causes of acute and chronic liver disease is the infection of the liver with hepatotropic viruses. Hepatitis B and C viruses are both linked to the autophagy. It has been shown that the X protein of the HBV (HBx) can induce autophagy due to its ability to bind to the PI3k autophagic molecule. On the other hand, the Hepatitis C virus (HCV) can adapt autophagy content to enhance its replication by inhibiting the maturation of autophagosome into autophagolysosomes. Both these viruses are shown to induce autophagy by transcriptional upregulation of Beclin1 [<xref rid="B19-cells-08-00091" ref-type="bibr">19</xref>].</p><p>Autophagy also plays a role in lipid metabolism and thus can influence the development of fatty liver disease, a rapidly increasing cause of chronic liver disease in the world. Hepatocytes are the main source for natural lipids stored in the form of triglycerides (TGs) and lipid droplets (LDs). Interestingly, the first degradation of lipid droplets through lipophagy was observed in mouse liver. It has been shown that ATg7 knockout mice showed significant increase levels of TGs and LDs in the hepatocytes leading to a decrease in the levels of free fatty acids (FFAs), necessary for ATP generation [<xref rid="B20-cells-08-00091" ref-type="bibr">20</xref>]. Another study illustrates the formation of hepatic steatosis in mice due to the consumption of a high-fat diet. This process occurs through autophagy activation in hepatic stellate cells and is due to the suppression of mTOR phosphorylation which increased expression of Sirt1 through the AMPK pathway [<xref rid="B21-cells-08-00091" ref-type="bibr">21</xref>].</p></sec><sec id="sec3-cells-08-00091"><title>3. Role of Autophagy in Hepatocellular Carcinoma</title><p>Hepatocellular carcinoma is one of the most common primary cancer and a major leading cause of death worldwide [<xref rid="B22-cells-08-00091" ref-type="bibr">22</xref>]. An estimation of 30,200 deaths is predicted this year [<xref rid="B23-cells-08-00091" ref-type="bibr">23</xref>]. The high proliferative capability of HCC cells has been linked to persistent inflammation and increased oxidative stress. Autophagy has been shown to play a dual role in cancer. Autophagy could be either tumor suppressive or tumor promoting. Here we review both the pro- and anti-tumor mechanism of autophagy that take place during the development and growth of HCC.</p><sec id="sec3dot1-cells-08-00091"><title>3.1. Tumor-Suppressive Role of Autophagy </title><p>Inflammation is recognized as a hallmark of cancer in promoting tumor growth and is associated with the poor prognosis of many solid tumors [<xref rid="B24-cells-08-00091" ref-type="bibr">24</xref>]. It is well known that HCC progression is highly correlated with the persistent inflammatory stimulation [<xref rid="B25-cells-08-00091" ref-type="bibr">25</xref>]. Autophagy has been suggested to prevent cancer progression by suppressing inflammation [<xref rid="B26-cells-08-00091" ref-type="bibr">26</xref>,<xref rid="B27-cells-08-00091" ref-type="bibr">27</xref>,<xref rid="B28-cells-08-00091" ref-type="bibr">28</xref>,<xref rid="B29-cells-08-00091" ref-type="bibr">29</xref>] while inhibition of autophagy can lead to a sustained and elevated level of inflammation [<xref rid="B30-cells-08-00091" ref-type="bibr">30</xref>,<xref rid="B31-cells-08-00091" ref-type="bibr">31</xref>]. Inflammasomes are the major drivers for chronic inflammation in the liver [<xref rid="B32-cells-08-00091" ref-type="bibr">32</xref>,<xref rid="B33-cells-08-00091" ref-type="bibr">33</xref>]. Interestingly, the capability of cells to suppress inflammation through autophagy was first observed in autophagic inhibited mice. Lack of autophagic responses in ATG16L1 knockout mice undergoing septic shock revealed an elevated level of inflammasome associated IL-1&#x003b2; and IL-18 cytokine production compared to wild-type controls [<xref rid="B28-cells-08-00091" ref-type="bibr">28</xref>]. Further studies showed that depletion of the autophagic proteins, LC3B and Beclin1, enhanced Caspase-1 activation which was NALP3 inflammasomes dependent. Mice lacking LC3B protein were more susceptible to LPS induced mortality [<xref rid="B34-cells-08-00091" ref-type="bibr">34</xref>]. In addition, a recent study showed the effect of chemokine (C-X-C motif) ligand 17 (CXCL17) in suppressing autophagy [<xref rid="B35-cells-08-00091" ref-type="bibr">35</xref>]. In human HCC tissues, elevated expression of CXCL17 has been observed which can also promote cell proliferation and migration when treated invitro. Silencing of this induced autophagy which is due to the enhanced nuclear translocation of liver kinase b1 (LKB1) that phosphorylates and activates AMPK. This lead to decrease in tumor volume and proliferation.</p><p>Beclin1, an important autophagic protein, has been shown to be associated with HCC tumors. The decreased Beclin1 expression observed in human HCC tissues correlated with tumor recurrence and disease-free survival [<xref rid="B36-cells-08-00091" ref-type="bibr">36</xref>]. Studies have also shown that knocking out Beclin1 in mice is embryonically lethal whereas heterogeneous Beclin1 mice developed spontaneous HCC [<xref rid="B37-cells-08-00091" ref-type="bibr">37</xref>]. In addition, normal hepatocytes show higher expression and activity of autophagic-associated proteins compared with HCC cell lines providing evidence that autophagy plays a tumor suppressive role [<xref rid="B14-cells-08-00091" ref-type="bibr">14</xref>]. A recent study demonstrated the effect of adrenaline in promoting hepatocarcinogenesis [<xref rid="B38-cells-08-00091" ref-type="bibr">38</xref>]. Treatment of adrenaline in DEN-induced HCC mice showed a remarkable increase in liver injury along with increased tumor number and tumor size. Mechanistically, increase in adrenaline activated the adrenergic receptors ADRB2 which inhibited autophagy activation by disrupting the Beclin1/VPS34/ATg14 complex.</p><p>Since autophagy plays a vital role in suppressing cancer inflammation, inhibition of autophagy has also been shown to result in an excessive accumulation of p62 protein [<xref rid="B39-cells-08-00091" ref-type="bibr">39</xref>]. P62 is an autophagic substrate which is used in measuring autophagic activity [<xref rid="B40-cells-08-00091" ref-type="bibr">40</xref>,<xref rid="B41-cells-08-00091" ref-type="bibr">41</xref>]. Transgenic P62 knockout animals displayed irregular cell mitotic activity with an increased expression of insulin-like growth factor 2 (IGF2) in their HCC tumors [<xref rid="B42-cells-08-00091" ref-type="bibr">42</xref>]. It has been reported that p62 is necessary for the HCC initiation by maintaining metabolic homeostasis through the mTOR pathway [<xref rid="B43-cells-08-00091" ref-type="bibr">43</xref>] and ablation of p62 inhibits growth and proliferation [<xref rid="B14-cells-08-00091" ref-type="bibr">14</xref>]. In a study, 90 HCC-resected tumors were analyzed for the accumulation of intracellular hyaline bodies (IHB) which are cytoplasmic inclusions consisting of p62. Patients with increased IHB were shown to be associated with significantly shorter overall survival [<xref rid="B44-cells-08-00091" ref-type="bibr">44</xref>]. Moreover. P62 is also known to interact with tumor necrosis factor receptor-associated factor 6 (TRAF6) that induces nuclear factor (NF-kB) activation [<xref rid="B45-cells-08-00091" ref-type="bibr">45</xref>]. Zhang et al. [<xref rid="B46-cells-08-00091" ref-type="bibr">46</xref>] have shown that DEAD-box protein 5 (DDX5), a tumor suppressor protein in the liver [<xref rid="B47-cells-08-00091" ref-type="bibr">47</xref>], binds to p62 and interferes with P62/TRAF6 interaction. This results in autophagy induction. However, the expression of DDX5 in the human HCC tumor tissues is relatively lower when compared to its non-tumor counterpart. Autophagy has also been shown to contribute to the anti-proliferative activity of interferon gamma (IFN-gamma), a pleiotropic cytokine that facilitates anti-viral and anti-proliferative effects in cancer cells. In HCC cell lines, stimulated autophagosome formation inhibited cell growth. Silencing of autophagy in these cells abolished the inhibitory effect, suggesting an essential anti-tumorigenic activity [<xref rid="B48-cells-08-00091" ref-type="bibr">48</xref>].</p><p>Similarly, multiple miRNAs which are found to target autophagic comprised genes for autophagy modulation [<xref rid="B49-cells-08-00091" ref-type="bibr">49</xref>,<xref rid="B50-cells-08-00091" ref-type="bibr">50</xref>,<xref rid="B51-cells-08-00091" ref-type="bibr">51</xref>] may also play a part in HCC growth and inhibition. miR-7 is a well acknowledged tumor suppressive microRNA in cancers. In HCC tumors, levels of miR-7 are significantly downregulated. It has been shown that upregulation of miR-7 in HCC cell lines increases autophagic activity by targeting the mTOR pathway, leading to a decrease in cancer cell proliferation [<xref rid="B52-cells-08-00091" ref-type="bibr">52</xref>]. miR-85 is an essential component during liver development and has also been linked as a tumor suppressor in HCC. In human HCC cell line HepG2, transfection of miR-85 upregulated autophagic activity which resulted in cell cycle arrest [<xref rid="B53-cells-08-00091" ref-type="bibr">53</xref>]. Our group has also previously shown that miR-375 is downregulated in HCC cell lines and tissues [<xref rid="B54-cells-08-00091" ref-type="bibr">54</xref>]. We found that miR-375 inhibits autophagy by suppressing the conversion of LC3I to LC3II by downregulating ATG7. Inoculating miR-375 overexpressed cells in nude mice showed significantly decreased tumor growth [<xref rid="B51-cells-08-00091" ref-type="bibr">51</xref>].</p></sec><sec id="sec3dot2-cells-08-00091"><title>3.2. Tumor-Promoting Role of Autophagy</title><p>Hypoxia-induced oxidative stress is one of the most prominent features in all solid tumors [<xref rid="B55-cells-08-00091" ref-type="bibr">55</xref>,<xref rid="B56-cells-08-00091" ref-type="bibr">56</xref>] due to the inadequate blood supply that tumors experience as they grow. Under oxygen deprivation, cells respond by regulating their metabolic and bioenergetics demands to overcome the hypoxic resistance [<xref rid="B57-cells-08-00091" ref-type="bibr">57</xref>,<xref rid="B58-cells-08-00091" ref-type="bibr">58</xref>,<xref rid="B59-cells-08-00091" ref-type="bibr">59</xref>]. Hypoxia-induced autophagy in hepatocytes and HCC tumor cells relies upon the stabilization of hypoxia-inducible factor (HIF1&#x003b1;). HIF is the important regulator that maintains oxygen homeostasis. It has been shown that HIF1-&#x003b1; upregulates BNIP3 and BNIP3L proteins which binds to the BCL-2 protein. This process inhibits the disruptive interaction between BCL-2 and Beclin1 [<xref rid="B60-cells-08-00091" ref-type="bibr">60</xref>] to induce autophagy for cellular survival in hypoxic conditions. In addition, hypoxia is also shown to upregulate early growth response gene-1 (Egr-1) expression. Egr-1 is a zinc finger nuclear protein and functions as a transcriptional regulator [<xref rid="B61-cells-08-00091" ref-type="bibr">61</xref>]. Upregulation of hypoxia induced Egr-1 has shown to induce autophagy in HCC cell lines promoting migration. Inhibiting Egr-1 function by Ad-DN-Egr-1 revealed the attenuated autophagosome formation due to inhibited binding of Egr-1 at LC3 promoter region (&#x02212;233 to &#x02212;214) [<xref rid="B62-cells-08-00091" ref-type="bibr">62</xref>].</p><p>The extensive reactive oxygen species generation during the developing tumor is the primary outcome of hypoxic stress. Increased ROS levels are shown to oxidize cellular components such as DNA, lipids, and proteins [<xref rid="B63-cells-08-00091" ref-type="bibr">63</xref>,<xref rid="B64-cells-08-00091" ref-type="bibr">64</xref>]. ROS can be generated by the NADPH oxidase complexes in the cell membrane, endoplasmic reticulum, peroxisomes, and mitochondria [<xref rid="B65-cells-08-00091" ref-type="bibr">65</xref>,<xref rid="B66-cells-08-00091" ref-type="bibr">66</xref>]. Tumors adapt different mechanisms to eliminates intracellular ROS, one of which is by the upregulation of anti-oxidant proteins NRF2 [<xref rid="B67-cells-08-00091" ref-type="bibr">67</xref>]. NRF2 is a cytoplasmic protein which translocates to the nucleus for the transcription of redox-balancing proteins and &#x003b2;-oxidant enzymes and is upregulated by autophagy. The autophagic protein p62 has been shown to interact with NRF2 [<xref rid="B68-cells-08-00091" ref-type="bibr">68</xref>]. Phosphorylated p62 binds with Keap1 (NRF2 inhibitory protein) allowing NRF2 release and cytosolic stabilization [<xref rid="B69-cells-08-00091" ref-type="bibr">69</xref>,<xref rid="B70-cells-08-00091" ref-type="bibr">70</xref>]. The clinical implication of NRF2 was elucidated in 107 HCC patients where patients that expressed higher levels of pNRF2 were significantly associated with worst disease-free survival and poor overall survival [<xref rid="B71-cells-08-00091" ref-type="bibr">71</xref>]. Thus, p62 induces the antioxidant activation pathway to prevent extreme organelle injury leading to tumor cell death.</p><p>Another important mechanism to control excess ROS production is by the removal of damaged organelles from the cell. Injured and non-functional mitochondria are the major source of cellular ROS production and the induction of mitophagy helps clear these damaged mitochondria to maintain cell function and bioenergetics [<xref rid="B72-cells-08-00091" ref-type="bibr">72</xref>,<xref rid="B73-cells-08-00091" ref-type="bibr">73</xref>]. Mitochondrial ROS is eliminated regularly by the superoxide dismutase within the cytosol [<xref rid="B74-cells-08-00091" ref-type="bibr">74</xref>,<xref rid="B75-cells-08-00091" ref-type="bibr">75</xref>] which is also activated by the NRF2 protein [<xref rid="B76-cells-08-00091" ref-type="bibr">76</xref>]. Depolarized mitochondria cleared via mitophagy are regulated by PINK1 and Parkin1 [<xref rid="B77-cells-08-00091" ref-type="bibr">77</xref>]. It is reported that mitophagy can degrade tumor suppressor p53 once localized to mitochondria and inhibit its subcellular localization. Mitophagy impairment results in p53 accumulation and its phosphorylation by PINK1 prevent hepatic cancer cell stemness [<xref rid="B78-cells-08-00091" ref-type="bibr">78</xref>]. However, excessive induction of mitophagy can also inhibit HCC migration. When yes-activated protein (Yap), a highly upregulated protein in HCC, is depleted, mitophagy is overactivated leading to cellular energy deprivation [<xref rid="B79-cells-08-00091" ref-type="bibr">79</xref>]. In contrast, the excessive activation of autophagy may also lead to autophagic cell death [<xref rid="B80-cells-08-00091" ref-type="bibr">80</xref>,<xref rid="B81-cells-08-00091" ref-type="bibr">81</xref>]. This process requires an additional cell death signaling, including the phosphorylation of c-Jun N-terminal kinase (JNK) [<xref rid="B82-cells-08-00091" ref-type="bibr">82</xref>]. Interestingly, the pro-apoptotic (Bax/Bak) deficient cells showed an autophagic cell death when exposed to apoptotic stimuli. This was driven through the increase in the level of JNK phosphorylation. However, treatment with the JNK inhibitor further revealed that a simultaneous activation of autophagy and JNK is required for the autophagic cell death. Numerous other cell death and tumor suppressor-related proteins are shown to trigger autophagic cell death in the literature [<xref rid="B83-cells-08-00091" ref-type="bibr">83</xref>,<xref rid="B84-cells-08-00091" ref-type="bibr">84</xref>,<xref rid="B85-cells-08-00091" ref-type="bibr">85</xref>].</p><p>Autophagy can also regulate inflammatory immune response by the release and degradation of damage associated molecular patterns (DAMPS) including high mobility group box 1 (HMGB1), histones, ATP, mitochondrial (mt)DNA, and mitochondrial transcription factor A (TFAM). HMGB1 is a well-characterized DAMP which can be released from necrotic or apoptotic hepatocytes [<xref rid="B86-cells-08-00091" ref-type="bibr">86</xref>,<xref rid="B87-cells-08-00091" ref-type="bibr">87</xref>]. Interestingly, autophagy-mediated intracellular mobilization of HMGB1 enables tumor growth by inducing cell survival and apoptosis [<xref rid="B88-cells-08-00091" ref-type="bibr">88</xref>,<xref rid="B89-cells-08-00091" ref-type="bibr">89</xref>]. We have previously shown that under hypoxic stress, HMGB1 translocates from nucleus to cytoplasm in HCC cells. Intracellular translocation of HMGB1 facilitates its interaction with mtDNA in the cytosol where together they activate TLR9 signaling pathways to enhance tumor growth [<xref rid="B90-cells-08-00091" ref-type="bibr">90</xref>].</p></sec><sec id="sec3dot3-cells-08-00091"><title>3.3. Autophagy in HCC Metastasis</title><p>Autophagy, due to its tumor promoting role, also plays a part in tumor metastasis. Increasing evidence suggests the upregulation of autophagy during the process of tumor metastasis [<xref rid="B91-cells-08-00091" ref-type="bibr">91</xref>,<xref rid="B92-cells-08-00091" ref-type="bibr">92</xref>]. As the primary tumor grows and encounter harsh microenvironment, part of it escapes and intravasates within the circulatory and lymphatic system, localizing at distal organs [<xref rid="B93-cells-08-00091" ref-type="bibr">93</xref>]. Cell detachment from the extracellular matrix (ECM) has demonstrated to trigger autophagy which then protects it from anoikis, a type of cell death induced in response to ECM detachment [<xref rid="B94-cells-08-00091" ref-type="bibr">94</xref>]. In addition, Autophagy can also induce changes in the cell adhesion signaling that facilitates invasion and migration [<xref rid="B95-cells-08-00091" ref-type="bibr">95</xref>].</p><p>Autophagy in hepatocellular carcinoma has shown to facilitate metastasis by upregulating the expression of epithelial&#x02013;mesenchymal transition (EMT). Induction of autophagy in the starved cells inhibited the expression of epithelial markers and induced mesenchymal expression along with cell invasion marker matrix metalloproteinase-9 (MMP9) [<xref rid="B96-cells-08-00091" ref-type="bibr">96</xref>]. These changes were regulated by the activation of TGF-beta and phosphorylation of Smad3 signaling pathway. In another study, inhibition of autophagy via silencing Beclin1 and ATG5 in HCC lung metastasis model markedly decreased distal metastasis to the lungs [<xref rid="B97-cells-08-00091" ref-type="bibr">97</xref>]. This effect is observed due to the impaired anoikis resistance that can suppress the colonization of HCC cells. However, silencing of autophagy mediators showed no effect in the expression of cell migration and invasion regulators.</p><p>Autophagy-mediated cancer cell metastasis can be stimulated by numerous stress factors persisting within the tumor microenvironment. One of which is the fluid shear stress (FSS). Wang et al. [<xref rid="B98-cells-08-00091" ref-type="bibr">98</xref>] showed that HCC cells, when exposed to 1.4 dyn/cm<sup>2</sup> of FSS, induce autophagy in a time-dependent manner. Furthermore, inhibition of autophagy attenuated cells to migrate and downregulate the expression of PI3K/FAK/Rho GTPase pathway. This suggests that the activation of autophagy via FSS is a PI3K/FAK/Rho GTPase-dependent pathway.</p></sec></sec><sec id="sec4-cells-08-00091"><title>4. Autophagy in HCC Therapy</title><p>As described above, autophagy can be either be pro- or anti-tumorigenic for HCC. Therefore, modulation of autophagy-based HCC therapy is very complex and will vary depending on the setting. Autophagy can suppress liver inflammation and thus decrease the carcinogenic environment in the liver but it can also promote and maintain tumor cell homeostasis by inducing mitophagy in growing HCC tumors. In addition, both the induction and inhibition of autophagy has been investigated to induce tumor cell death [<xref rid="B99-cells-08-00091" ref-type="bibr">99</xref>,<xref rid="B100-cells-08-00091" ref-type="bibr">100</xref>]. Currently, there are a variety of therapeutic agents that are being used either individually or in combination with other agents for anti-HCC therapy. The current agents used to selectively target autophagy to induce HCC cell death are described in <xref rid="cells-08-00091-t001" ref-type="table">Table 1</xref>.</p><sec id="sec4dot1-cells-08-00091"><title>4.1. Autophagy Inducers</title><p>The autophagy inducer sorafenib is the first-line drug used for the treatment of advanced HCC [<xref rid="B101-cells-08-00091" ref-type="bibr">101</xref>]. Currently, sorafenib is the only drug that has been shown to improve HCC patient survival [<xref rid="B102-cells-08-00091" ref-type="bibr">102</xref>]. In a randomized controlled trial, patients with advanced HCC treated with sorafenib had an improved rate of overall survival compared to patients given placebo. Sorafenib has been shown to promote cell death through the upregulation of autophagy via myeloid cell leukemia-1 (Mcl-1) signaling pathway [<xref rid="B103-cells-08-00091" ref-type="bibr">103</xref>]. In addition, sorafenib can also inhibit tumor growth by targeting the RAF/MEK/ERK pathway to induce cell cycle arrest [<xref rid="B104-cells-08-00091" ref-type="bibr">104</xref>]. Besides Mcl-1 and ERK pathways, sorafenib can also inhibit the activation of PI3K/AKT/mTOR pathways which initiates a signaling cascade for autophagy induction [<xref rid="B105-cells-08-00091" ref-type="bibr">105</xref>,<xref rid="B106-cells-08-00091" ref-type="bibr">106</xref>]. In a recent study, sorafenib is also shown to regulate cell endoplasmic reticulum (ER) stress, JNK, Akt, and AMPK pathway leading to elevated autophagy which later shifts towards apoptosis [<xref rid="B107-cells-08-00091" ref-type="bibr">107</xref>]. At an early time point (3&#x02013;12 h) sorafenib increases ER stress which is shown to induce the autophagic survival process in HCC cell line by regulating JNK/AMPK signaling pathway. At a later stage (24 h), a significant increase in the ER stress and PERK-CHOP dependent rise of Bim shifted autophagy to apoptosis cell death.</p><p>Besides its tumor suppressing function, long term sorafenib treatment has also shown to trigger chemo-resistance in HCC cells [<xref rid="B108-cells-08-00091" ref-type="bibr">108</xref>]. Thus, the combination of sorafenib with SAHA, another autophagy-inducer, has been used to improve responses against HCC compared to treating with sorafenib alone [<xref rid="B109-cells-08-00091" ref-type="bibr">109</xref>]. Sustained treatment of sorafenib has also shown to increase tumor hypoxic environment that leads to decrease treatment efficiency [<xref rid="B110-cells-08-00091" ref-type="bibr">110</xref>]. Combination of melatonin with sorafenib has shown to enhance sorafenib&#x02019;s cytotoxicity against human HCC cells by decreasing hypoxic resistance [<xref rid="B111-cells-08-00091" ref-type="bibr">111</xref>]. Co-administration diminished the expression of BNIP3 and NIX, hypoxia induced mitophagy mediators. Due to the common occurrence of tumor resistance, the combinations of different drugs with sorafenib are currently being studied to increase chemo-sensitivity and decrease tumor growth. A detailed combination of reagents with sorafenib are extensively reviewed elsewhere [<xref rid="B112-cells-08-00091" ref-type="bibr">112</xref>].</p></sec><sec id="sec4dot2-cells-08-00091"><title>4.2. Autophagy Inhibitors</title><p>Since autophagy can be utilized by the growing cancer cells for its survival and add resistance towards chemotherapeutic reagents, inhibiting autophagy can also be a promising strategy against cancer therapy. At present chloroquine (CQ), an anti-malarial drug, can be used for the inhibition of autophagy through the suppression of lysosomes. Treatment with CQ neutralizes the pH levels of lysosomes required in the final stages of autophagy for degradation [<xref rid="B113-cells-08-00091" ref-type="bibr">113</xref>]. CQ is being effectively used in patients with the combination of drugs capable of inducing cell apoptosis such as oxaliplatin [<xref rid="B114-cells-08-00091" ref-type="bibr">114</xref>]. It is reported that co-treatment of proliferative HCC cell lines with CQ and sorafenib can lead to a marked suppression of its growth [<xref rid="B105-cells-08-00091" ref-type="bibr">105</xref>]. In a liver xenograft tumor model, nude mice treated with CQ and sorafenib combined achieved a higher level of tumor regression compared to treatment with sorafenib alone. In addition, 3-methyladenine (3-MA) which inhibits the interaction of autophagosomes and lysosomes can enhance anti-HCC therapy when combined with cisplatin, doxorubicin, and sorafenib [<xref rid="B115-cells-08-00091" ref-type="bibr">115</xref>]. Similarly, suppression of autophagy by administration of 3-MA and inactive ATg4B suppresses the proliferation of Huh7 cells [<xref rid="B116-cells-08-00091" ref-type="bibr">116</xref>]. Hence, inhibition of autophagy can promote the death of HCC cells but these treatments with their known side effects highlight a major risk in triggering the neoplasticism within the normal hepatocytes.</p></sec></sec><sec id="sec5-cells-08-00091"><title>5. Concluding Remarks</title><p>Autophagy is the vital response for hepatocytes undergoing stress in the maintenance of cellular homeostasis and quality control. As we outlined in this review, evidence supports a dual role of autophagy in the progression of HCC (<xref ref-type="fig" rid="cells-08-00091-f001">Figure 1</xref>). Targeting autophagy can be used to treat liver cancer. However, caution should be noted as autophagy can inhibit the development of HCC but also act as a tumor promoter resulting resistance to HCC tumor therapy [<xref rid="B137-cells-08-00091" ref-type="bibr">137</xref>]. Multiple direct and indirect interactions including complex mechanistic overlap between apoptotic and autophagic cell death have been studied [<xref rid="B138-cells-08-00091" ref-type="bibr">138</xref>,<xref rid="B139-cells-08-00091" ref-type="bibr">139</xref>]. Many studies indicate that the apoptotic events alter autophagy. However, the molecular role of autophagy controlling apoptosis requires further investigation. In the developing tumor microenvironment, hypoxia is a common stimulus in many cancers and hepatotropic viruses can induce a hypoxic environment initiating hypoxic oxidative and inflammatory responses [<xref rid="B140-cells-08-00091" ref-type="bibr">140</xref>]. Thus improving tumor oxygenation or suppressing hypoxia-induced autophagy signaling could be a potential future therapeutic pathway to target. We currently have a minimal understanding regarding the stress signaling that takes part in the complex coordination of autophagy to respond during different intracellular and extracellular stimuli in HCC. Additional studies are necessary to further elucidate the mechanisms underlying autophagy&#x02019;s role in HCC.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Jannat Malik for linguistic revision.</p></ack><notes><title>Funding</title><p>This work is supported by the grants from National Institute of Health, CA214865-01 (AT) and GM095566-06 (AT).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declared nothing to disclose regarding the conflict of interest concerning this paper.</p></notes><ref-list><title>References</title><ref id="B1-cells-08-00091"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Klionsky</surname><given-names>D.J.</given-names></name></person-group><article-title>Autophagosome formation: Core machinery and adaptations</article-title><source>Nat. Cell Biol.</source><year>2007</year><volume>9</volume><fpage>1102</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1038/ncb1007-1102</pub-id><pub-id pub-id-type="pmid">17909521</pub-id></element-citation></ref><ref id="B2-cells-08-00091"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devenish</surname><given-names>R.J.</given-names></name><name><surname>Klionsky</surname><given-names>D.J.</given-names></name></person-group><article-title>Autophagy: Mechanism and physiological relevance &#x0201c;brewed&#x0201d; from yeast studies</article-title><source>Front. Biosci.</source><year>2012</year><volume>54</volume><fpage>1354</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.2741/s337</pub-id></element-citation></ref><ref id="B3-cells-08-00091"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>E.</given-names></name></person-group><article-title>The role for autophagy in cancer</article-title><source>J. Clin. Investig.</source><year>2015</year><volume>125</volume><fpage>42</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1172/JCI73941</pub-id><pub-id pub-id-type="pmid">25654549</pub-id></element-citation></ref><ref id="B4-cells-08-00091"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy: Renovation of Cells and Tissues</article-title><source>Cell</source><year>2011</year><volume>147</volume><fpage>728</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.026</pub-id><pub-id pub-id-type="pmid">22078875</pub-id></element-citation></ref><ref id="B5-cells-08-00091"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Klionsky</surname><given-names>D.J.</given-names></name></person-group><article-title>Autophagy and human disease</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>1837</fpage><lpage>1849</lpage><pub-id pub-id-type="doi">10.4161/cc.6.15.4511</pub-id><pub-id pub-id-type="pmid">17671424</pub-id></element-citation></ref><ref id="B6-cells-08-00091"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yorimitsu</surname><given-names>T.</given-names></name><name><surname>Klionsky</surname><given-names>D.J.</given-names></name></person-group><article-title>Autophagy: Molecular machinery for self-eating</article-title><source>Cell Death Differ.</source><year>2005</year><volume>12</volume><fpage>1542</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401765</pub-id><pub-id pub-id-type="pmid">16247502</pub-id></element-citation></ref><ref id="B7-cells-08-00091"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwanten</surname><given-names>W.J.</given-names></name><name><surname>Martinet</surname><given-names>W.</given-names></name><name><surname>Michielsen</surname><given-names>P.P.</given-names></name><name><surname>Francque</surname><given-names>S.M.</given-names></name></person-group><article-title>Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue</article-title><source>World J. Gastroenterol.</source><year>2014</year><volume>20</volume><fpage>7325</fpage><lpage>7338</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i23.7325</pub-id><pub-id pub-id-type="pmid">24966603</pub-id></element-citation></ref><ref id="B8-cells-08-00091"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>H.-M.</given-names></name></person-group><article-title>The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets</article-title><source>Biochim. Biophys. Acta Rev. Cancer</source><year>2013</year><volume>1836</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2013.02.003</pub-id></element-citation></ref><ref id="B9-cells-08-00091"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portolani</surname><given-names>N.</given-names></name><name><surname>Coniglio</surname><given-names>A.</given-names></name><name><surname>Ghidoni</surname><given-names>S.</given-names></name><name><surname>Giovanelli</surname><given-names>M.</given-names></name><name><surname>Benetti</surname><given-names>A.</given-names></name><name><surname>Tiberio</surname><given-names>G.A.M.</given-names></name><name><surname>Giulini</surname><given-names>S.M.</given-names></name></person-group><article-title>Early and Late Recurrence after Liver Resection for Hepatocellular Carcinoma</article-title><source>Ann. Surg.</source><year>2006</year><volume>243</volume><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1097/01.sla.0000197706.21803.a1</pub-id><pub-id pub-id-type="pmid">16432356</pub-id></element-citation></ref><ref id="B10-cells-08-00091"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>E.</given-names></name></person-group><article-title>Deconvoluting the context-dependent role for autophagy in cancer</article-title><source>Nat. Rev. Cancer</source><year>2012</year><volume>12</volume><fpage>401</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nrc3262</pub-id><pub-id pub-id-type="pmid">22534666</pub-id></element-citation></ref><ref id="B11-cells-08-00091"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janku</surname><given-names>F.</given-names></name><name><surname>McConkey</surname><given-names>D.J.</given-names></name><name><surname>Hong</surname><given-names>D.S.</given-names></name><name><surname>Kurzrock</surname><given-names>R.</given-names></name></person-group><article-title>Autophagy as a target for anticancer therapy</article-title><source>Nat. Rev. Clin. Oncol.</source><year>2011</year><volume>8</volume><fpage>528</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2011.71</pub-id><pub-id pub-id-type="pmid">21587219</pub-id></element-citation></ref><ref id="B12-cells-08-00091"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Waguri</surname><given-names>S.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Iwata</surname><given-names>J.</given-names></name><name><surname>Murata</surname><given-names>S.</given-names></name><name><surname>Tanida</surname><given-names>I.</given-names></name><name><surname>Ezaki</surname><given-names>J.</given-names></name><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Ohsumi</surname><given-names>Y.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice</article-title><source>J. Cell Biol.</source><year>2005</year><volume>169</volume><fpage>425</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1083/jcb.200412022</pub-id><pub-id pub-id-type="pmid">15866887</pub-id></element-citation></ref><ref id="B13-cells-08-00091"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>W.-X.</given-names></name></person-group><article-title>Role of autophagy in liver physiology and pathophysiology</article-title><source>World J. Biol. Chem.</source><year>2010</year><volume>1</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.4331/wjbc.v1.i1.3</pub-id><pub-id pub-id-type="pmid">21540988</pub-id></element-citation></ref><ref id="B14-cells-08-00091"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamura</surname><given-names>A.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Sakamoto</surname><given-names>A.</given-names></name><name><surname>Kishi</surname><given-names>C.</given-names></name><name><surname>Waguri</surname><given-names>S.</given-names></name><name><surname>Eishi</surname><given-names>Y.</given-names></name><name><surname>Hino</surname><given-names>O.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Mizushima</surname><given-names>N.</given-names></name></person-group><article-title>Autophagy-deficient mice develop multiple liver tumors</article-title><source>Genes Dev.</source><year>2011</year><volume>25</volume><fpage>795</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1101/gad.2016211</pub-id><pub-id pub-id-type="pmid">21498569</pub-id></element-citation></ref><ref id="B15-cells-08-00091"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhi</surname><given-names>H.</given-names></name><name><surname>Gores</surname><given-names>G.J.</given-names></name></person-group><article-title>Cellular and Molecular Mechanisms of Liver Injury</article-title><source>Gastroenterology</source><year>2008</year><volume>134</volume><fpage>1641</fpage><lpage>1654</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2008.03.002</pub-id><pub-id pub-id-type="pmid">18471544</pub-id></element-citation></ref><ref id="B16-cells-08-00091"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy in the liver: Functions in health and disease</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2017</year><volume>14</volume><fpage>170</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2016.185</pub-id><pub-id pub-id-type="pmid">28053338</pub-id></element-citation></ref><ref id="B17-cells-08-00091"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rautou</surname><given-names>P.E.</given-names></name><name><surname>Mansouri</surname><given-names>A.</given-names></name><name><surname>Lebrec</surname><given-names>D.</given-names></name><name><surname>Durand</surname><given-names>F.</given-names></name><name><surname>Valla</surname><given-names>D.</given-names></name><name><surname>Moreau</surname><given-names>R.</given-names></name></person-group><article-title>Autophagy in liver diseases</article-title><source>J. Hepatol.</source><year>2010</year><volume>53</volume><fpage>1123</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2010.07.006</pub-id><pub-id pub-id-type="pmid">20810185</pub-id></element-citation></ref><ref id="B18-cells-08-00091"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Sui</surname><given-names>X.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name></person-group><article-title>Autophagy: A novel therapeutic target for hepatocarcinoma (Review)</article-title><source>Oncol. Lett.</source><year>2014</year><volume>7</volume><fpage>1345</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.3892/ol.2014.1916</pub-id><pub-id pub-id-type="pmid">24765136</pub-id></element-citation></ref><ref id="B19-cells-08-00091"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdoli</surname><given-names>A.</given-names></name><name><surname>Alirezaei</surname><given-names>M.</given-names></name><name><surname>Mehrbod</surname><given-names>P.</given-names></name><name><surname>Forouzanfar</surname><given-names>F.</given-names></name></person-group><article-title>Autophagy: The multi-purpose bridge in viral infections and host cells</article-title><source>Rev. Med. Virol.</source><year>2018</year><volume>28</volume><fpage>e1973</fpage><pub-id pub-id-type="doi">10.1002/rmv.1973</pub-id><pub-id pub-id-type="pmid">29709097</pub-id></element-citation></ref><ref id="B20-cells-08-00091"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>Y.</given-names></name><name><surname>Novak</surname><given-names>I.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Cuervo</surname><given-names>A.M.</given-names></name><name><surname>Czaja</surname><given-names>M.J.</given-names></name></person-group><article-title>Autophagy regulates lipid metabolism</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>1131</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1038/nature07976</pub-id><pub-id pub-id-type="pmid">19339967</pub-id></element-citation></ref><ref id="B21-cells-08-00091"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Kanasaki</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Kitada</surname><given-names>M.</given-names></name><name><surname>Nagao</surname><given-names>K.</given-names></name><name><surname>Jinzu</surname><given-names>H.</given-names></name><name><surname>Noguchi</surname><given-names>Y.</given-names></name><name><surname>Maegawa</surname><given-names>H.</given-names></name><name><surname>Kanasaki</surname><given-names>K.</given-names></name><name><surname>Koya</surname><given-names>D.</given-names></name></person-group><article-title>Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules</article-title><source>Biochim. Biophys. Acta Mol. Basis Dis.</source><year>2013</year><volume>1832</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2013.05.003</pub-id><pub-id pub-id-type="pmid">23669346</pub-id></element-citation></ref><ref id="B22-cells-08-00091"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Miller</surname><given-names>K.D.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Cancer statistics, 2017</article-title><source>CA Cancer J. Clin.</source><year>2017</year><volume>67</volume><fpage>7</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.3322/caac.21387</pub-id><pub-id pub-id-type="pmid">28055103</pub-id></element-citation></ref><ref id="B23-cells-08-00091"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auld</surname><given-names>S.K.J.R.</given-names></name><name><surname>Scholefield</surname><given-names>J.A.</given-names></name><name><surname>Little</surname><given-names>T.J.</given-names></name></person-group><article-title>Genetic variation in the cellular response of Daphnia magna (Crustacea: Cladocera) to its bacterial parasite</article-title><source>Proc. Biol. Sci.</source><year>2010</year><volume>277</volume><fpage>3291</fpage><lpage>3297</lpage><pub-id pub-id-type="doi">10.1098/rspb.2010.0772</pub-id><pub-id pub-id-type="pmid">20534618</pub-id></element-citation></ref><ref id="B24-cells-08-00091"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J.-H.</given-names></name><name><surname>Huang</surname><given-names>D.-H.</given-names></name><name><surname>Chen</surname><given-names>Z.-Y.</given-names></name></person-group><article-title>Prognostic role of systemic immune-inflammation index in solid tumors: A systematic review and meta-analysis</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>75381</fpage><lpage>75388</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.18856</pub-id><pub-id pub-id-type="pmid">29088873</pub-id></element-citation></ref><ref id="B25-cells-08-00091"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arzumanyan</surname><given-names>A.</given-names></name><name><surname>Reis</surname><given-names>H.M.</given-names></name><name><surname>Feitelson</surname><given-names>M.A.</given-names></name></person-group><article-title>Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma</article-title><source>Nat. Rev. Cancer</source><year>2013</year><volume>13</volume><fpage>123</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nrc3449</pub-id><pub-id pub-id-type="pmid">23344543</pub-id></element-citation></ref><ref id="B26-cells-08-00091"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Sung</surname><given-names>J.J.Y.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Ng</surname><given-names>S.C.</given-names></name><name><surname>Wong</surname><given-names>S.H.</given-names></name><name><surname>Cho</surname><given-names>C.H.</given-names></name><name><surname>Ng</surname><given-names>S.S.M.</given-names></name><name><surname>Chan</surname><given-names>F.K.L.</given-names></name><name><surname>Wu</surname><given-names>W.K.K.</given-names></name></person-group><article-title>Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer</article-title><source>J. Pathol.</source><year>2014</year><volume>233</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1002/path.4351</pub-id><pub-id pub-id-type="pmid">24633785</pub-id></element-citation></ref><ref id="B27-cells-08-00091"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibutani</surname><given-names>S.T.</given-names></name><name><surname>Saitoh</surname><given-names>T.</given-names></name><name><surname>Nowag</surname><given-names>H.</given-names></name><name><surname>M&#x000fc;nz</surname><given-names>C.</given-names></name><name><surname>Yoshimori</surname><given-names>T.</given-names></name></person-group><article-title>Autophagy and autophagy-related proteins in the immune system</article-title><source>Nat. Immunol.</source><year>2015</year><volume>16</volume><fpage>1014</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1038/ni.3273</pub-id><pub-id pub-id-type="pmid">26382870</pub-id></element-citation></ref><ref id="B28-cells-08-00091"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>N.</given-names></name><name><surname>Jang</surname><given-names>M.H.</given-names></name><name><surname>Uematsu</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>B.-G.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Omori</surname><given-names>H.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1&#x003b2; production</article-title><source>Nature</source><year>2008</year><volume>456</volume><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1038/nature07383</pub-id><pub-id pub-id-type="pmid">18849965</pub-id></element-citation></ref><ref id="B29-cells-08-00091"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Yazdi</surname><given-names>A.S.</given-names></name><name><surname>Menu</surname><given-names>P.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>A role for mitochondria in NLRP3 inflammasome activation</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature09663</pub-id><pub-id pub-id-type="pmid">21124315</pub-id></element-citation></ref><ref id="B30-cells-08-00091"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujak</surname><given-names>A.L.</given-names></name><name><surname>Crane</surname><given-names>J.D.</given-names></name><name><surname>Lally</surname><given-names>J.S.</given-names></name><name><surname>Ford</surname><given-names>R.J.</given-names></name><name><surname>Kang</surname><given-names>S.J.</given-names></name><name><surname>Rebalka</surname><given-names>I.A.</given-names></name><name><surname>Green</surname><given-names>A.E.</given-names></name><name><surname>Kemp</surname><given-names>B.E.</given-names></name><name><surname>Hawke</surname><given-names>T.J.</given-names></name><name><surname>Schertzer</surname><given-names>J.D.</given-names></name><etal/></person-group><article-title>AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging</article-title><source>Cell Metab.</source><year>2015</year><volume>21</volume><fpage>883</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.016</pub-id><pub-id pub-id-type="pmid">26039451</pub-id></element-citation></ref><ref id="B31-cells-08-00091"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Sanchez-Lopez</surname><given-names>E.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment</article-title><source>Cell</source><year>2016</year><volume>166</volume><fpage>288</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.051</pub-id><pub-id pub-id-type="pmid">27419869</pub-id></element-citation></ref><ref id="B32-cells-08-00091"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mridha</surname><given-names>A.R.</given-names></name><name><surname>Wree</surname><given-names>A.</given-names></name><name><surname>Robertson</surname><given-names>A.A.B.</given-names></name><name><surname>Yeh</surname><given-names>M.M.</given-names></name><name><surname>Johnson</surname><given-names>C.D.</given-names></name><name><surname>Van Rooyen</surname><given-names>D.M.</given-names></name><name><surname>Haczeyni</surname><given-names>F.</given-names></name><name><surname>Teoh</surname><given-names>N.C.H.</given-names></name><name><surname>Savard</surname><given-names>C.</given-names></name><name><surname>Ioannou</surname><given-names>G.N.</given-names></name><etal/></person-group><article-title>NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice</article-title><source>J. Hepatol.</source><year>2017</year><volume>66</volume><fpage>1037</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2017.01.022</pub-id><pub-id pub-id-type="pmid">28167322</pub-id></element-citation></ref><ref id="B33-cells-08-00091"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrasek</surname><given-names>J.</given-names></name><name><surname>Bala</surname><given-names>S.</given-names></name><name><surname>Csak</surname><given-names>T.</given-names></name><name><surname>Lippai</surname><given-names>D.</given-names></name><name><surname>Kodys</surname><given-names>K.</given-names></name><name><surname>Menashy</surname><given-names>V.</given-names></name><name><surname>Barrieau</surname><given-names>M.</given-names></name><name><surname>Min</surname><given-names>S.-Y.</given-names></name><name><surname>Kurt-Jones</surname><given-names>E.A.</given-names></name><name><surname>Szabo</surname><given-names>G.</given-names></name></person-group><article-title>IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice</article-title><source>J. Clin. Investig.</source><year>2012</year><volume>122</volume><fpage>3476</fpage><lpage>3489</lpage><pub-id pub-id-type="doi">10.1172/JCI60777</pub-id><pub-id pub-id-type="pmid">22945633</pub-id></element-citation></ref><ref id="B34-cells-08-00091"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahira</surname><given-names>K.</given-names></name><name><surname>Haspel</surname><given-names>J.A.</given-names></name><name><surname>Rathinam</surname><given-names>V.A.K.</given-names></name><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>Dolinay</surname><given-names>T.</given-names></name><name><surname>Lam</surname><given-names>H.C.</given-names></name><name><surname>Englert</surname><given-names>J.A.</given-names></name><name><surname>Rabinovitch</surname><given-names>M.</given-names></name><name><surname>Cernadas</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H.P.</given-names></name><etal/></person-group><article-title>Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome</article-title><source>Nat. Immunol.</source><year>2011</year><volume>12</volume><fpage>222</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/ni.1980</pub-id><pub-id pub-id-type="pmid">21151103</pub-id></element-citation></ref><ref id="B35-cells-08-00091"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhen</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name></person-group><article-title>CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma</article-title><source>Gene</source><year>2019</year><volume>690</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2018.12.043</pub-id><pub-id pub-id-type="pmid">30597237</pub-id></element-citation></ref><ref id="B36-cells-08-00091"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotsafti</surname><given-names>A.</given-names></name><name><surname>Farinati</surname><given-names>F.</given-names></name><name><surname>Cardin</surname><given-names>R.</given-names></name><name><surname>Cillo</surname><given-names>U.</given-names></name><name><surname>Nitti</surname><given-names>D.</given-names></name><name><surname>Bortolami</surname><given-names>M.</given-names></name></person-group><article-title>Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma</article-title><source>BMC Gastroenterol.</source><year>2012</year><volume>12</volume><elocation-id>118</elocation-id><pub-id pub-id-type="doi">10.1186/1471-230X-12-118</pub-id><pub-id pub-id-type="pmid">22928777</pub-id></element-citation></ref><ref id="B37-cells-08-00091"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Levine</surname><given-names>A.J.</given-names></name><name><surname>Heintz</surname><given-names>N.</given-names></name></person-group><article-title>Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>15077</fpage><lpage>15082</lpage><pub-id pub-id-type="doi">10.1073/pnas.2436255100</pub-id><pub-id pub-id-type="pmid">14657337</pub-id></element-citation></ref><ref id="B38-cells-08-00091"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.-Q.</given-names></name><name><surname>Fang</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>L.-X.</given-names></name><name><surname>Lv</surname><given-names>G.-S.</given-names></name><name><surname>Lv</surname><given-names>H.-W.</given-names></name><name><surname>Liang</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>C.-Z.</given-names></name><name><surname>Tan</surname><given-names>Y.-X.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><etal/></person-group><article-title>ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1&#x003b1;</article-title><source>J. Hepatol.</source><year>2016</year><volume>65</volume><fpage>314</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.04.019</pub-id><pub-id pub-id-type="pmid">27154061</pub-id></element-citation></ref><ref id="B39-cells-08-00091"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pursiheimo</surname><given-names>J.-P.</given-names></name><name><surname>Rantanen</surname><given-names>K.</given-names></name><name><surname>Heikkinen</surname><given-names>P.T.</given-names></name><name><surname>Johansen</surname><given-names>T.</given-names></name><name><surname>Jaakkola</surname><given-names>P.M.</given-names></name></person-group><article-title>Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>334</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.392</pub-id><pub-id pub-id-type="pmid">18931699</pub-id></element-citation></ref><ref id="B40-cells-08-00091"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Waguri</surname><given-names>S.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Sou</surname><given-names>Y.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Iwata</surname><given-names>J.</given-names></name><name><surname>Ezaki</surname><given-names>J.</given-names></name><name><surname>Murata</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>1149</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.035</pub-id><pub-id pub-id-type="pmid">18083104</pub-id></element-citation></ref><ref id="B41-cells-08-00091"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshii</surname><given-names>S.R.</given-names></name><name><surname>Mizushima</surname><given-names>N.</given-names></name></person-group><article-title>Monitoring and Measuring Autophagy</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>1865</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18091865</pub-id><pub-id pub-id-type="pmid">28846632</pub-id></element-citation></ref><ref id="B42-cells-08-00091"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>S.M.</given-names></name><name><surname>Laggai</surname><given-names>S.</given-names></name><name><surname>Barghash</surname><given-names>A.</given-names></name><name><surname>Schultheiss</surname><given-names>C.S.</given-names></name><name><surname>Lederer</surname><given-names>E.</given-names></name><name><surname>Artl</surname><given-names>M.</given-names></name><name><surname>Helms</surname><given-names>V.</given-names></name><name><surname>Haybaeck</surname><given-names>J.</given-names></name><name><surname>Kiemer</surname><given-names>A.K.</given-names></name></person-group><article-title>IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype</article-title><source>Cell Death Dis.</source><year>2015</year><volume>6</volume><fpage>e1894</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.241</pub-id><pub-id pub-id-type="pmid">26426686</pub-id></element-citation></ref><ref id="B43-cells-08-00091"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umemura</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Taniguchi</surname><given-names>K.</given-names></name><name><surname>Nakagawa</surname><given-names>H.</given-names></name><name><surname>Yamachika</surname><given-names>S.</given-names></name><name><surname>Font-Burgada</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Subramaniam</surname><given-names>S.</given-names></name><name><surname>Raghunandan</surname><given-names>S.</given-names></name><name><surname>Duran</surname><given-names>A.</given-names></name><etal/></person-group><article-title>p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells</article-title><source>Cancer Cell</source><year>2016</year><volume>29</volume><fpage>935</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.04.006</pub-id><pub-id pub-id-type="pmid">27211490</pub-id></element-citation></ref><ref id="B44-cells-08-00091"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aigelsreiter</surname><given-names>A.</given-names></name><name><surname>Neumann</surname><given-names>J.</given-names></name><name><surname>Pichler</surname><given-names>M.</given-names></name><name><surname>Halasz</surname><given-names>J.</given-names></name><name><surname>Zatloukal</surname><given-names>K.</given-names></name><name><surname>Berghold</surname><given-names>A.</given-names></name><name><surname>Douschan</surname><given-names>P.</given-names></name><name><surname>Rainer</surname><given-names>F.</given-names></name><name><surname>Stauber</surname><given-names>R.</given-names></name><name><surname>Haybaeck</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis</article-title><source>Liver Int.</source><year>2017</year><volume>37</volume><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1111/liv.13325</pub-id><pub-id pub-id-type="pmid">27885796</pub-id></element-citation></ref><ref id="B45-cells-08-00091"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscat</surname><given-names>J.</given-names></name><name><surname>Diaz-Meco</surname><given-names>M.T.</given-names></name></person-group><article-title>p62 at the Crossroads of Autophagy, Apoptosis, and Cancer</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>1001</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.05.023</pub-id><pub-id pub-id-type="pmid">19524504</pub-id></element-citation></ref><ref id="B46-cells-08-00091"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Andrisani</surname><given-names>O.</given-names></name><name><surname>Kong</surname><given-names>L.</given-names></name></person-group><article-title>DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1</article-title><source>Hepatology</source><year>2018</year><pub-id pub-id-type="doi">10.1002/hep.30300</pub-id><pub-id pub-id-type="pmid">30281815</pub-id></element-citation></ref><ref id="B47-cells-08-00091"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicol</surname><given-names>S.M.</given-names></name><name><surname>Bray</surname><given-names>S.E.</given-names></name><name><surname>Derek Black</surname><given-names>H.</given-names></name><name><surname>Lorimore</surname><given-names>S.A.</given-names></name><name><surname>Wright</surname><given-names>E.G.</given-names></name><name><surname>Lane</surname><given-names>D.P.</given-names></name><name><surname>Meek</surname><given-names>D.W.</given-names></name><name><surname>Coates</surname><given-names>P.J.</given-names></name><name><surname>Fuller-Pace</surname><given-names>F.V.</given-names></name></person-group><article-title>The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage</article-title><source>Oncogene</source><year>2013</year><volume>32</volume><fpage>3461</fpage><lpage>3469</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.426</pub-id><pub-id pub-id-type="pmid">22986526</pub-id></element-citation></ref><ref id="B48-cells-08-00091"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Du</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Evankovich</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name><name><surname>Stolz</surname><given-names>D.B.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1)</article-title><source>Cancer Lett.</source><year>2012</year><volume>314</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2011.09.031</pub-id><pub-id pub-id-type="pmid">22056812</pub-id></element-citation></ref><ref id="B49-cells-08-00091"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>C.-G.</given-names></name><name><surname>Yang</surname><given-names>J.-M.</given-names></name></person-group><article-title>Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells</article-title><source>Autophagy</source><year>2009</year><volume>5</volume><fpage>816</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.4161/auto.9064</pub-id><pub-id pub-id-type="pmid">19535919</pub-id></element-citation></ref><ref id="B50-cells-08-00091"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankel</surname><given-names>L.B.</given-names></name><name><surname>Wen</surname><given-names>J.</given-names></name><name><surname>Lees</surname><given-names>M.</given-names></name><name><surname>H&#x000f8;yer-Hansen</surname><given-names>M.</given-names></name><name><surname>Farkas</surname><given-names>T.</given-names></name><name><surname>Krogh</surname><given-names>A.</given-names></name><name><surname>J&#x000e4;&#x000e4;ttel&#x000e4;</surname><given-names>M.</given-names></name><name><surname>Lund</surname><given-names>A.H.</given-names></name></person-group><article-title>microRNA-101 is a potent inhibitor of autophagy</article-title><source>EMBO J.</source><year>2011</year><volume>30</volume><fpage>4628</fpage><lpage>4641</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.331</pub-id><pub-id pub-id-type="pmid">21915098</pub-id></element-citation></ref><ref id="B51-cells-08-00091"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Nace</surname><given-names>G.</given-names></name><name><surname>Geller</surname><given-names>D.A.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name></person-group><article-title>MiR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions</article-title><source>Gastroenterology</source><year>2012</year><volume>143</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2012.04.009</pub-id><pub-id pub-id-type="pmid">22504094</pub-id></element-citation></ref><ref id="B52-cells-08-00091"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name></person-group><article-title>Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells</article-title><source>Oncol. Lett.</source><year>2017</year><volume>14</volume><fpage>3566</fpage><lpage>3572</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.6573</pub-id><pub-id pub-id-type="pmid">28927113</pub-id></element-citation></ref><ref id="B53-cells-08-00091"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Feng</surname><given-names>S.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>MicroRNA-185 induces potent autophagy via AKT signaling in hepatocellular carcinoma</article-title><source>Tumour Biol.</source><year>2017</year><volume>39</volume><fpage>1010428317694313</fpage><pub-id pub-id-type="doi">10.1177/1010428317694313</pub-id><pub-id pub-id-type="pmid">28240051</pub-id></element-citation></ref><ref id="B54-cells-08-00091"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name></person-group><article-title>Manipulation of autophagy by MIR375 generates antitumor effects in liver cancer</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><fpage>1833</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.4161/auto.21796</pub-id><pub-id pub-id-type="pmid">22929050</pub-id></element-citation></ref><ref id="B55-cells-08-00091"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>C.C.-L.</given-names></name><name><surname>Kai</surname><given-names>A.K.-L.</given-names></name><name><surname>Ng</surname><given-names>I.O.-L.</given-names></name></person-group><article-title>The impact of hypoxia in hepatocellular carcinoma metastasis</article-title><source>Front. Med.</source><year>2014</year><volume>8</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s11684-013-0301-3</pub-id><pub-id pub-id-type="pmid">24234682</pub-id></element-citation></ref><ref id="B56-cells-08-00091"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>G.K.</given-names></name><name><surname>Tennant</surname><given-names>D.A.</given-names></name><name><surname>McKeating</surname><given-names>J.A.</given-names></name></person-group><article-title>Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions</article-title><source>J. Hepatol.</source><year>2014</year><volume>61</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2014.08.025</pub-id><pub-id pub-id-type="pmid">25157983</pub-id></element-citation></ref><ref id="B57-cells-08-00091"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eales</surname><given-names>K.L.</given-names></name><name><surname>Hollinshead</surname><given-names>K.E.R.</given-names></name><name><surname>Tennant</surname><given-names>D.A.</given-names></name></person-group><article-title>Hypoxia and metabolic adaptation of cancer cells</article-title><source>Oncogenesis</source><year>2016</year><volume>61</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/oncsis.2015.50</pub-id></element-citation></ref><ref id="B58-cells-08-00091"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohme</surname><given-names>S.</given-names></name><name><surname>Yazdani</surname><given-names>H.O.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Loughran</surname><given-names>P.</given-names></name><name><surname>van der Windt</surname><given-names>D.J.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Simmons</surname><given-names>R.L.</given-names></name><name><surname>Shiva</surname><given-names>S.</given-names></name><name><surname>Tai</surname><given-names>S.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name></person-group><article-title>Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction</article-title><source>Hepatology</source><year>2017</year><volume>66</volume><fpage>182</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1002/hep.29184</pub-id><pub-id pub-id-type="pmid">28370295</pub-id></element-citation></ref><ref id="B59-cells-08-00091"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schito</surname><given-names>L.</given-names></name><name><surname>Rey</surname><given-names>S.</given-names></name></person-group><article-title>Cell-Autonomous Metabolic Reprogramming in Hypoxia</article-title><source>Trends Cell Biol.</source><year>2018</year><volume>28</volume><fpage>128</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.10.006</pub-id><pub-id pub-id-type="pmid">29191366</pub-id></element-citation></ref><ref id="B60-cells-08-00091"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellot</surname><given-names>G.</given-names></name><name><surname>Garcia-Medina</surname><given-names>R.</given-names></name><name><surname>Gounon</surname><given-names>P.</given-names></name><name><surname>Chiche</surname><given-names>J.</given-names></name><name><surname>Roux</surname><given-names>D.</given-names></name><name><surname>Pouyssegur</surname><given-names>J.</given-names></name><name><surname>Mazure</surname><given-names>N.M.</given-names></name></person-group><article-title>Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains</article-title><source>Mol. Cell. Biol.</source><year>2009</year><volume>29</volume><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1128/MCB.00166-09</pub-id><pub-id pub-id-type="pmid">19273585</pub-id></element-citation></ref><ref id="B61-cells-08-00091"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sijtsema</surname><given-names>W.Y.</given-names></name></person-group><article-title>Sport voor mensen met een handicap</article-title><source>Tijdschrift voor Ziekenverpleging</source><year>1977</year><volume>30</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">138964</pub-id></element-citation></ref><ref id="B62-cells-08-00091"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W.X.</given-names></name><name><surname>Xiong</surname><given-names>E.M.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Wan</surname><given-names>Y.Y.</given-names></name><name><surname>Zhang</surname><given-names>C.L.</given-names></name><name><surname>Du</surname><given-names>F.Y.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Bhat</surname><given-names>R.A.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>A.H.</given-names></name></person-group><article-title>Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells</article-title><source>Exp. Cell Res.</source><year>2016</year><volume>340</volume><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2015.12.006</pub-id><pub-id pub-id-type="pmid">26708617</pub-id></element-citation></ref><ref id="B63-cells-08-00091"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjelland</surname><given-names>S.</given-names></name><name><surname>Seeberg</surname><given-names>E.</given-names></name></person-group><article-title>Mutagenicity, toxicity and repair of DNA base damage induced by oxidation</article-title><source>Mutat. Res.</source><year>2003</year><volume>531</volume><fpage>37</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2003.07.002</pub-id><pub-id pub-id-type="pmid">14637246</pub-id></element-citation></ref><ref id="B64-cells-08-00091"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherz-Shouval</surname><given-names>R.</given-names></name><name><surname>Elazar</surname><given-names>Z.</given-names></name></person-group><article-title>ROS, mitochondria and the regulation of autophagy</article-title><source>Trends Cell Biol.</source><year>2007</year><volume>17</volume><fpage>422</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2007.07.009</pub-id><pub-id pub-id-type="pmid">17804237</pub-id></element-citation></ref><ref id="B65-cells-08-00091"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>D.</given-names></name><name><surname>Williams</surname><given-names>E.</given-names></name><name><surname>Cadenas</surname><given-names>E.</given-names></name></person-group><article-title>Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space</article-title><source>Biochem. J.</source><year>2001</year><volume>353</volume><fpage>411</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1042/bj3530411</pub-id><pub-id pub-id-type="pmid">11139407</pub-id></element-citation></ref><ref id="B66-cells-08-00091"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>F.</given-names></name></person-group><article-title>The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging</article-title><source>Age</source><year>2000</year><volume>23</volume><fpage>227</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1007/s11357-000-0022-9</pub-id><pub-id pub-id-type="pmid">23604868</pub-id></element-citation></ref><ref id="B67-cells-08-00091"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Lamark</surname><given-names>T.</given-names></name><name><surname>Sj&#x000f8;ttem</surname><given-names>E.</given-names></name><name><surname>Larsen</surname><given-names>K.B.</given-names></name><name><surname>Awuh</surname><given-names>J.A.</given-names></name><name><surname>&#x000d8;vervatn</surname><given-names>A.</given-names></name><name><surname>McMahon</surname><given-names>M.</given-names></name><name><surname>Hayes</surname><given-names>J.D.</given-names></name><name><surname>Johansen</surname><given-names>T.</given-names></name></person-group><article-title>p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>22576</fpage><lpage>22591</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.118976</pub-id><pub-id pub-id-type="pmid">20452972</pub-id></element-citation></ref><ref id="B68-cells-08-00091"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copple</surname><given-names>I.M.</given-names></name><name><surname>Lister</surname><given-names>A.</given-names></name><name><surname>Obeng</surname><given-names>A.D.</given-names></name><name><surname>Kitteringham</surname><given-names>N.R.</given-names></name><name><surname>Jenkins</surname><given-names>R.E.</given-names></name><name><surname>Layfield</surname><given-names>R.</given-names></name><name><surname>Foster</surname><given-names>B.J.</given-names></name><name><surname>Goldring</surname><given-names>C.E.</given-names></name><name><surname>Park</surname><given-names>B.K.</given-names></name></person-group><article-title>Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>16782</fpage><lpage>16788</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.096545</pub-id><pub-id pub-id-type="pmid">20378532</pub-id></element-citation></ref><ref id="B69-cells-08-00091"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuragi</surname><given-names>Y.</given-names></name><name><surname>Ichimura</surname><given-names>Y.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name></person-group><article-title>Regulation of the Keap1&#x02013;Nrf2 pathway by p62/SQSTM1</article-title><source>Curr. Opin. Toxicol.</source><year>2016</year><volume>1</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.cotox.2016.09.005</pub-id></element-citation></ref><ref id="B70-cells-08-00091"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolini</surname><given-names>D.</given-names></name><name><surname>Dallaglio</surname><given-names>K.</given-names></name><name><surname>Torquato</surname><given-names>P.</given-names></name><name><surname>Piroddi</surname><given-names>M.</given-names></name><name><surname>Galli</surname><given-names>F.</given-names></name></person-group><article-title>Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma</article-title><source>Transl. Res.</source><year>2018</year><volume>193</volume><fpage>54</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2017.11.007</pub-id><pub-id pub-id-type="pmid">29274776</pub-id></element-citation></ref><ref id="B71-cells-08-00091"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>Q.</given-names></name><name><surname>Kang</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma</article-title><source>Cancer Med.</source><year>2016</year><volume>5</volume><fpage>2678</fpage><lpage>2687</lpage><pub-id pub-id-type="doi">10.1002/cam4.788</pub-id><pub-id pub-id-type="pmid">27650414</pub-id></element-citation></ref><ref id="B72-cells-08-00091"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemasters</surname><given-names>J.J.</given-names></name></person-group><article-title>Selective Mitochondrial Autophagy, or Mitophagy, as a Targeted Defense against Oxidative Stress, Mitochondrial Dysfunction, and Aging</article-title><source>Rejuv. Res.</source><year>2005</year><volume>8</volume><fpage>3</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1089/rej.2005.8.3</pub-id><pub-id pub-id-type="pmid">15798367</pub-id></element-citation></ref><ref id="B73-cells-08-00091"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>P.</given-names></name><name><surname>Dikic</surname><given-names>I.</given-names></name></person-group><article-title>Mitochondria get a Parkin&#x02019; ticket</article-title><source>Nat. Cell Biol.</source><year>2010</year><volume>12</volume><fpage>104</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/ncb0210-104</pub-id><pub-id pub-id-type="pmid">20118996</pub-id></element-citation></ref><ref id="B74-cells-08-00091"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>K.</given-names></name><name><surname>Krause</surname><given-names>K.-H.</given-names></name></person-group><article-title>The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology</article-title><source>Physiol. Rev.</source><year>2007</year><volume>87</volume><fpage>245</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1152/physrev.00044.2005</pub-id><pub-id pub-id-type="pmid">17237347</pub-id></element-citation></ref><ref id="B75-cells-08-00091"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambeth</surname><given-names>J.D.</given-names></name></person-group><article-title>NOX enzymes and the biology of reactive oxygen</article-title><source>Nat. Rev. Immunol.</source><year>2004</year><volume>4</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1038/nri1312</pub-id><pub-id pub-id-type="pmid">15039755</pub-id></element-citation></ref><ref id="B76-cells-08-00091"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Q.</given-names></name></person-group><article-title>Role of Nrf2 in Oxidative Stress and Toxicity</article-title><source>Annu. Rev. Pharmacol. Toxicol.</source><year>2013</year><volume>53</volume><fpage>401</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-011112-140320</pub-id><pub-id pub-id-type="pmid">23294312</pub-id></element-citation></ref><ref id="B77-cells-08-00091"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twig</surname><given-names>G.</given-names></name><name><surname>Elorza</surname><given-names>A.</given-names></name><name><surname>Molina</surname><given-names>A.J.A.</given-names></name><name><surname>Mohamed</surname><given-names>H.</given-names></name><name><surname>Wikstrom</surname><given-names>J.D.</given-names></name><name><surname>Walzer</surname><given-names>G.</given-names></name><name><surname>Stiles</surname><given-names>L.</given-names></name><name><surname>Haigh</surname><given-names>S.E.</given-names></name><name><surname>Katz</surname><given-names>S.</given-names></name><name><surname>Las</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Fission and selective fusion govern mitochondrial segregation and elimination by autophagy</article-title><source>EMBO J.</source><year>2008</year><volume>27</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601963</pub-id><pub-id pub-id-type="pmid">18200046</pub-id></element-citation></ref><ref id="B78-cells-08-00091"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Chan</surname><given-names>S.T.</given-names></name><name><surname>Cho</surname><given-names>C.</given-names></name><name><surname>Machida</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Ou</surname><given-names>J.-H.J.</given-names></name></person-group><article-title>Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells</article-title><source>Mol. Cell</source><year>2017</year><volume>68</volume><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.022</pub-id><pub-id pub-id-type="pmid">29033320</pub-id></element-citation></ref><ref id="B79-cells-08-00091"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name></person-group><article-title>Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways</article-title><source>Redox Biol.</source><year>2018</year><volume>14</volume><fpage>59</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.08.013</pub-id><pub-id pub-id-type="pmid">28869833</pub-id></element-citation></ref><ref id="B80-cells-08-00091"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inbal</surname><given-names>B.</given-names></name><name><surname>Bialik</surname><given-names>S.</given-names></name><name><surname>Sabanay</surname><given-names>I.</given-names></name><name><surname>Shani</surname><given-names>G.</given-names></name><name><surname>Kimchi</surname><given-names>A.</given-names></name></person-group><article-title>DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death</article-title><source>J. Cell Biol.</source><year>2002</year><volume>157</volume><fpage>455</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1083/jcb.200109094</pub-id><pub-id pub-id-type="pmid">11980920</pub-id></element-citation></ref><ref id="B81-cells-08-00091"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasari</surname><given-names>S.K.</given-names></name><name><surname>Bialik</surname><given-names>S.</given-names></name><name><surname>Levin-Zaidman</surname><given-names>S.</given-names></name><name><surname>Levin-Salomon</surname><given-names>V.</given-names></name><name><surname>Merrill</surname><given-names>A.H.</given-names></name><name><surname>Futerman</surname><given-names>A.H.</given-names></name><name><surname>Kimchi</surname><given-names>A.</given-names></name></person-group><article-title>Signalome-wide RNAi screen identifies GBA1 as a positive mediator of autophagic cell death</article-title><source>Cell Death Differ.</source><year>2017</year><volume>24</volume><fpage>1288</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.80</pub-id><pub-id pub-id-type="pmid">28574511</pub-id></element-citation></ref><ref id="B82-cells-08-00091"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>S.</given-names></name><name><surname>Konishi</surname><given-names>A.</given-names></name><name><surname>Nishida</surname><given-names>Y.</given-names></name><name><surname>Mizuta</surname><given-names>T.</given-names></name><name><surname>Nishina</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Tsujimoto</surname><given-names>Y.</given-names></name></person-group><article-title>Involvement of JNK in the regulation of autophagic cell death</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>2070</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.487</pub-id><pub-id pub-id-type="pmid">20101227</pub-id></element-citation></ref><ref id="B83-cells-08-00091"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>S.</given-names></name><name><surname>Tsujioka</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Tajima-Sakurai</surname><given-names>H.</given-names></name><name><surname>Nishida</surname><given-names>Y.</given-names></name><name><surname>Matsuoka</surname><given-names>Y.</given-names></name><name><surname>Yoshino</surname><given-names>I.</given-names></name><name><surname>Tsujimoto</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>S.</given-names></name></person-group><article-title>Role of Atg5-dependent cell death in the embryonic development of Bax/Bak double-knockout mice</article-title><source>Cell Death Differ.</source><year>2017</year><volume>24</volume><fpage>1598</fpage><lpage>1608</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.84</pub-id><pub-id pub-id-type="pmid">28574506</pub-id></element-citation></ref><ref id="B84-cells-08-00091"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reef</surname><given-names>S.</given-names></name><name><surname>Zalckvar</surname><given-names>E.</given-names></name><name><surname>Shifman</surname><given-names>O.</given-names></name><name><surname>Bialik</surname><given-names>S.</given-names></name><name><surname>Sabanay</surname><given-names>H.</given-names></name><name><surname>Oren</surname><given-names>M.</given-names></name><name><surname>Kimchi</surname><given-names>A.</given-names></name></person-group><article-title>A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death</article-title><source>Mol. Cell</source><year>2006</year><volume>22</volume><fpage>463</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.04.014</pub-id><pub-id pub-id-type="pmid">16713577</pub-id></element-citation></ref><ref id="B85-cells-08-00091"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>H.</given-names></name><name><surname>Miyashita</surname><given-names>T.</given-names></name><name><surname>Nakano</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>D.</given-names></name></person-group><article-title>HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death</article-title><source>Cell Death Differ.</source><year>2003</year><volume>10</volume><fpage>798</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401246</pub-id><pub-id pub-id-type="pmid">12815463</pub-id></element-citation></ref><ref id="B86-cells-08-00091"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Varley</surname><given-names>P.</given-names></name><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>X.X.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Lotze</surname><given-names>M.T.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name></person-group><article-title>High-mobility group box 1 promotes hepatocellular carcinoma progression through MIR-21-mediated matrix metalloproteinase activity</article-title><source>Cancer Res.</source><year>2015</year><volume>75</volume><fpage>1645</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-2147</pub-id><pub-id pub-id-type="pmid">25720799</pub-id></element-citation></ref><ref id="B87-cells-08-00091"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Nace</surname><given-names>G.W.</given-names></name><name><surname>McDonald</surname><given-names>K.-A.</given-names></name><name><surname>Tai</surname><given-names>S.</given-names></name><name><surname>Klune</surname><given-names>J.R.</given-names></name><name><surname>Rosborough</surname><given-names>B.R.</given-names></name><name><surname>Ding</surname><given-names>Q.</given-names></name><name><surname>Loughran</surname><given-names>P.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Beer-Stolz</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high-mobility group box 1 in cellular protection</article-title><source>Hepatology</source><year>2014</year><volume>59</volume><fpage>1984</fpage><lpage>1997</lpage><pub-id pub-id-type="doi">10.1002/hep.26976</pub-id><pub-id pub-id-type="pmid">24375466</pub-id></element-citation></ref><ref id="B88-cells-08-00091"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Feng</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title>HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma</article-title><source>Mol. Cancer</source><year>2014</year><volume>13</volume><fpage>165</fpage><pub-id pub-id-type="doi">10.1186/1476-4598-13-165</pub-id><pub-id pub-id-type="pmid">24996221</pub-id></element-citation></ref><ref id="B89-cells-08-00091"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><etal/></person-group><article-title>HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells</article-title><source>BMB Rep.</source><year>2011</year><volume>44</volume><fpage>601</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2011.44.9.601</pub-id><pub-id pub-id-type="pmid">21944254</pub-id></element-citation></ref><ref id="B90-cells-08-00091"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Tohme</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>D.</given-names></name><name><surname>Lotze</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Tsung</surname><given-names>A.</given-names></name></person-group><article-title>Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9</article-title><source>J. Hepatol.</source><year>2015</year><volume>63</volume><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2015.02.009</pub-id><pub-id pub-id-type="pmid">25681553</pub-id></element-citation></ref><ref id="B91-cells-08-00091"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>J.</given-names></name></person-group><article-title>Detachment-induced autophagy during anoikis and lumen formation in epithelial acini</article-title><source>Autophagy</source><year>2008</year><volume>4</volume><fpage>351</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.4161/auto.5523</pub-id><pub-id pub-id-type="pmid">18196957</pub-id></element-citation></ref><ref id="B92-cells-08-00091"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y.-F.</given-names></name><name><surname>Shi</surname><given-names>Y.-H.</given-names></name><name><surname>Shen</surname><given-names>Y.-H.</given-names></name><name><surname>Ding</surname><given-names>Z.-B.</given-names></name><name><surname>Ke</surname><given-names>A.-W.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>S.-J.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name></person-group><article-title>Promoting colonization in metastatic HCC cells by modulation of autophagy</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e74407</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0074407</pub-id><pub-id pub-id-type="pmid">24058558</pub-id></element-citation></ref><ref id="B93-cells-08-00091"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyfried</surname><given-names>T.N.</given-names></name><name><surname>Huysentruyt</surname><given-names>L.C.</given-names></name></person-group><article-title>On the Origin of Cancer Metastasis</article-title><source>Crit. Rev. Oncog.</source><year>2013</year><volume>18</volume><fpage>43</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1615/CritRevOncog.v18.i1-2.40</pub-id><pub-id pub-id-type="pmid">23237552</pub-id></element-citation></ref><ref id="B94-cells-08-00091"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avivar-Valderas</surname><given-names>A.</given-names></name><name><surname>Salas</surname><given-names>E.</given-names></name><name><surname>Bobrovnikova-Marjon</surname><given-names>E.</given-names></name><name><surname>Diehl</surname><given-names>J.A.</given-names></name><name><surname>Nagi</surname><given-names>C.</given-names></name><name><surname>Debnath</surname><given-names>J.</given-names></name><name><surname>Aguirre-Ghiso</surname><given-names>J.A.</given-names></name></person-group><article-title>PERK Integrates Autophagy and Oxidative Stress Responses To Promote Survival during Extracellular Matrix Detachment</article-title><source>Mol. Cell. Biol.</source><year>2011</year><volume>31</volume><fpage>3616</fpage><lpage>3629</lpage><pub-id pub-id-type="doi">10.1128/MCB.05164-11</pub-id><pub-id pub-id-type="pmid">21709020</pub-id></element-citation></ref><ref id="B95-cells-08-00091"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi</surname><given-names>M.N.</given-names></name><name><surname>Mowers</surname><given-names>E.E.</given-names></name><name><surname>Drake</surname><given-names>L.E.</given-names></name><name><surname>Collier</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Zamora</surname><given-names>M.</given-names></name><name><surname>Mui</surname><given-names>S.</given-names></name><name><surname>Macleod</surname><given-names>K.F.</given-names></name></person-group><article-title>Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3</article-title><source>Cell Rep.</source><year>2016</year><volume>15</volume><fpage>1660</fpage><lpage>1672</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.065</pub-id><pub-id pub-id-type="pmid">27184837</pub-id></element-citation></ref><ref id="B96-cells-08-00091"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Shang</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Xiong</surname><given-names>J.</given-names></name></person-group><article-title>Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial&#x02013;mesenchymal transition</article-title><source>Carcinogenesis</source><year>2013</year><volume>34</volume><fpage>1343</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgt063</pub-id><pub-id pub-id-type="pmid">23430956</pub-id></element-citation></ref><ref id="B97-cells-08-00091"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y.F.</given-names></name><name><surname>Shi</surname><given-names>Y.H.</given-names></name><name><surname>Ding</surname><given-names>Z.B</given-names></name><name><surname>Ke</surname><given-names>A.W.</given-names></name><name><surname>Gu</surname><given-names>C.Y.</given-names></name><name><surname>Hui</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>S.J.</given-names></name><name><surname>Dai</surname><given-names>Z.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name></person-group><article-title>Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells</article-title><source>Autophagy</source><year>2013</year><volume>9</volume><fpage>2056</fpage><lpage>2068</lpage><pub-id pub-id-type="doi">10.4161/auto.26398</pub-id><pub-id pub-id-type="pmid">24157892</pub-id></element-citation></ref><ref id="B98-cells-08-00091"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>G.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Fluid shear stress promotes autophagy in hepatocellular carcinoma cells</article-title><source>Int. J. Biol. Sci.</source><year>2018</year><volume>14</volume><fpage>1277</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.7150/ijbs.27055</pub-id><pub-id pub-id-type="pmid">30123076</pub-id></element-citation></ref><ref id="B99-cells-08-00091"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H.-M.</given-names></name><name><surname>Codogno</surname><given-names>P.</given-names></name></person-group><article-title>Autophagic cell death: Loch Ness monster or endangered species?</article-title><source>Autophagy</source><year>2011</year><volume>7</volume><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.4161/auto.7.5.14226</pub-id><pub-id pub-id-type="pmid">21150268</pub-id></element-citation></ref><ref id="B100-cells-08-00091"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya</surname><given-names>P.</given-names></name><name><surname>Gonzalez-Polo</surname><given-names>R.-A.</given-names></name><name><surname>Casares</surname><given-names>N.</given-names></name><name><surname>Perfettini</surname><given-names>J.-L.</given-names></name><name><surname>Dessen</surname><given-names>P.</given-names></name><name><surname>Larochette</surname><given-names>N.</given-names></name><name><surname>Metivier</surname><given-names>D.</given-names></name><name><surname>Meley</surname><given-names>D.</given-names></name><name><surname>Souquere</surname><given-names>S.</given-names></name><name><surname>Yoshimori</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Inhibition of Macroautophagy Triggers Apoptosis</article-title><source>Mol. Cell. Biol.</source><year>2005</year><volume>25</volume><fpage>1025</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.3.1025-1040.2005</pub-id><pub-id pub-id-type="pmid">15657430</pub-id></element-citation></ref><ref id="B101-cells-08-00091"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A.-L.</given-names></name><name><surname>Kang</surname><given-names>Y.-K.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Tsao</surname><given-names>C.-J.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J.S.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>T.-S.</given-names></name><etal/></person-group><article-title>Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial</article-title><source>Lancet Oncol.</source><year>2009</year><volume>10</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(08)70285-7</pub-id><pub-id pub-id-type="pmid">19095497</pub-id></element-citation></ref><ref id="B102-cells-08-00091"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Rahman</surname><given-names>O.</given-names></name><name><surname>Fouad</surname><given-names>M.</given-names></name></person-group><article-title>Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature</article-title><source>Crit. Rev. Oncol. Hematol.</source><year>2014</year><volume>91</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2013.12.013</pub-id><pub-id pub-id-type="pmid">24457121</pub-id></element-citation></ref><ref id="B103-cells-08-00091"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decaens</surname><given-names>T.</given-names></name><name><surname>Luciani</surname><given-names>A.</given-names></name><name><surname>Itti</surname><given-names>E.</given-names></name><name><surname>Hulin</surname><given-names>A.</given-names></name><name><surname>Roudot-Thoraval</surname><given-names>F.</given-names></name><name><surname>Laurent</surname><given-names>A.</given-names></name><name><surname>Zafrani</surname><given-names>E.S.</given-names></name><name><surname>Mallat</surname><given-names>A.</given-names></name><name><surname>Duvoux</surname><given-names>C.</given-names></name></person-group><article-title>Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma</article-title><source>Dig. Liver Dis.</source><year>2012</year><volume>44</volume><fpage>610</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/j.dld.2012.02.005</pub-id><pub-id pub-id-type="pmid">22459565</pub-id></element-citation></ref><ref id="B104-cells-08-00091"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adnane</surname><given-names>L.</given-names></name><name><surname>Trail</surname><given-names>P.A.</given-names></name><name><surname>Taylor</surname><given-names>I.</given-names></name><name><surname>Wilhelm</surname><given-names>S.M.</given-names></name></person-group><article-title>Sorafenib (BAY 43-9006, Nexavar<sup>&#x000ae;</sup>), a Dual-Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature</article-title><source>Methods Enzymol.</source><year>2006</year><volume>407</volume><fpage>597</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">16757355</pub-id></element-citation></ref><ref id="B105-cells-08-00091"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>S.</given-names></name><name><surname>Takehara</surname><given-names>T.</given-names></name><name><surname>Hikita</surname><given-names>H.</given-names></name><name><surname>Kodama</surname><given-names>T.</given-names></name><name><surname>Tsunematsu</surname><given-names>H.</given-names></name><name><surname>Miyagi</surname><given-names>T.</given-names></name><name><surname>Hosui</surname><given-names>A.</given-names></name><name><surname>Ishida</surname><given-names>H.</given-names></name><name><surname>Tatsumi</surname><given-names>T.</given-names></name><name><surname>Kanto</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma</article-title><source>Int. J. Cancer</source><year>2012</year><volume>131</volume><fpage>548</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1002/ijc.26374</pub-id><pub-id pub-id-type="pmid">21858812</pub-id></element-citation></ref><ref id="B106-cells-08-00091"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedaly</surname><given-names>R.</given-names></name><name><surname>Angulo</surname><given-names>P.</given-names></name><name><surname>Hundley</surname><given-names>J.</given-names></name><name><surname>Daily</surname><given-names>M.F.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Evers</surname><given-names>B.M.</given-names></name></person-group><article-title>PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation</article-title><source>J. Surg. Res.</source><year>2012</year><volume>176</volume><fpage>542</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2011.10.045</pub-id><pub-id pub-id-type="pmid">22261591</pub-id></element-citation></ref><ref id="B107-cells-08-00091"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Hern&#x000e1;ndez</surname><given-names>M.A.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>R.</given-names></name><name><surname>de la Rosa</surname><given-names>&#x000c1;.J.</given-names></name><name><surname>Gallego</surname><given-names>P.</given-names></name><name><surname>Ord&#x000f3;&#x000f1;ez</surname><given-names>R.</given-names></name><name><surname>Navarro-Villar&#x000e1;n</surname><given-names>E.</given-names></name><name><surname>Contreras</surname><given-names>L.</given-names></name><name><surname>Rodr&#x000ed;guez-Arribas</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>&#x000c1;lamo-Mart&#x000ed;nez</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells</article-title><source>J. Cell. Physiol.</source><year>2019</year><volume>234</volume><fpage>692</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1002/jcp.26855</pub-id><pub-id pub-id-type="pmid">30132846</pub-id></element-citation></ref><ref id="B108-cells-08-00091"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>N.</given-names></name><name><surname>Kitano</surname><given-names>M.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Kudo</surname><given-names>M.</given-names></name></person-group><article-title>Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma</article-title><source>Dig. Dis.</source><year>2015</year><volume>33</volume><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1159/000439102</pub-id><pub-id pub-id-type="pmid">26488287</pub-id></element-citation></ref><ref id="B109-cells-08-00091"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachenmayer</surname><given-names>A.</given-names></name><name><surname>Toffanin</surname><given-names>S.</given-names></name><name><surname>Cabellos</surname><given-names>L.</given-names></name><name><surname>Alsinet</surname><given-names>C.</given-names></name><name><surname>Hoshida</surname><given-names>Y.</given-names></name><name><surname>Villanueva</surname><given-names>A.</given-names></name><name><surname>Minguez</surname><given-names>B.</given-names></name><name><surname>Tsai</surname><given-names>H.W.</given-names></name><name><surname>Ward</surname><given-names>S.C.</given-names></name><name><surname>Thung</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib</article-title><source>J. Hepatol.</source><year>2012</year><volume>56</volume><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2012.01.009</pub-id><pub-id pub-id-type="pmid">22322234</pub-id></element-citation></ref><ref id="B110-cells-08-00091"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>X.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1&#x003b1; inhibition in hepatocellular carcinoma</article-title><source>Hepatology</source><year>2013</year><volume>57</volume><fpage>1847</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1002/hep.26224</pub-id><pub-id pub-id-type="pmid">23299930</pub-id></element-citation></ref><ref id="B111-cells-08-00091"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prieto-Dom&#x000ed;nguez</surname><given-names>N.</given-names></name><name><surname>M&#x000e9;ndez-Blanco</surname><given-names>C.</given-names></name><name><surname>Carbajo-Pescador</surname><given-names>S.</given-names></name><name><surname>Fondevila</surname><given-names>F.</given-names></name><name><surname>Garc&#x000ed;a-Palomo</surname><given-names>A.</given-names></name><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>Mauriz</surname><given-names>J.L.</given-names></name></person-group><article-title>Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1&#x003b1; and hypoxia-mediated mitophagy</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>91402</fpage><lpage>91414</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.20592</pub-id><pub-id pub-id-type="pmid">29207653</pub-id></element-citation></ref><ref id="B112-cells-08-00091"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prieto-Dom&#x000ed;nguez</surname><given-names>N.</given-names></name><name><surname>Ord&#x000f3;&#x000f1;ez</surname><given-names>R.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>A.</given-names></name><name><surname>Garc&#x000ed;a-Palomo</surname><given-names>A.</given-names></name><name><surname>Muntan&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>Mauriz</surname><given-names>J.L.</given-names></name></person-group><article-title>Modulation of Autophagy by Sorafenib: Effects on Treatment Response</article-title><source>Front. Pharmacol.</source><year>2016</year><volume>7</volume><fpage>151</fpage><pub-id pub-id-type="doi">10.3389/fphar.2016.00151</pub-id><pub-id pub-id-type="pmid">27375485</pub-id></element-citation></ref><ref id="B113-cells-08-00091"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhi</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>Q.</given-names></name></person-group><article-title>Autophagy in cancer</article-title><source>F1000Prime Rep.</source><year>2015</year><volume>7</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.12703/P7-18</pub-id><pub-id pub-id-type="pmid">25750736</pub-id></element-citation></ref><ref id="B114-cells-08-00091"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Z.-B.</given-names></name><name><surname>Hui</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>Y.-H.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>Y.-F.</given-names></name><name><surname>Gu</surname><given-names>C.-Y.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>G.-M.</given-names></name><name><surname>Ke</surname><given-names>A.-W.</given-names></name><name><surname>Wang</surname><given-names>X.-Y.</given-names></name><etal/></person-group><article-title>Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation</article-title><source>Clin. Cancer Res.</source><year>2011</year><volume>17</volume><fpage>6229</fpage><lpage>6238</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-0816</pub-id><pub-id pub-id-type="pmid">21825039</pub-id></element-citation></ref><ref id="B115-cells-08-00091"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>J.</given-names></name><name><surname>Qin</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma</article-title><source>Am. J. Cancer Res.</source><year>2018</year><volume>8</volume><fpage>354</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">29636994</pub-id></element-citation></ref><ref id="B116-cells-08-00091"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toshima</surname><given-names>T.</given-names></name><name><surname>Shirabe</surname><given-names>K.</given-names></name><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Yoshiya</surname><given-names>S.</given-names></name><name><surname>Ikegami</surname><given-names>T.</given-names></name><name><surname>Yoshizumi</surname><given-names>T.</given-names></name><name><surname>Soejima</surname><given-names>Y.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Maehara</surname><given-names>Y.</given-names></name></person-group><article-title>Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial &#x003b2;-oxidation</article-title><source>J. Gastroenterol.</source><year>2014</year><volume>49</volume><fpage>907</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1007/s00535-013-0835-9</pub-id><pub-id pub-id-type="pmid">23702609</pub-id></element-citation></ref><ref id="B117-cells-08-00091"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Cheng</surname><given-names>B.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Meng</surname><given-names>Z.</given-names></name></person-group><article-title>Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/&#x003b2;-catenin signaling</article-title><source>Oncotargets Ther.</source><year>2018</year><volume>11</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.2147/OTT.S150520</pub-id></element-citation></ref><ref id="B118-cells-08-00091"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>E.F.G.</given-names></name><name><surname>Krause</surname><given-names>G.C.</given-names></name><name><surname>Lima</surname><given-names>K.G.</given-names></name><name><surname>Haute</surname><given-names>G.V.</given-names></name><name><surname>Pedrazza</surname><given-names>L.</given-names></name><name><surname>Mesquita</surname><given-names>F.C.</given-names></name><name><surname>Basso</surname><given-names>B.S.</given-names></name><name><surname>Velasquez</surname><given-names>A.C.</given-names></name><name><surname>Nunes</surname><given-names>F.B.</given-names></name><name><surname>De Oliveira</surname><given-names>J.R.</given-names></name></person-group><article-title>Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis</article-title><source>Oncol. Rep.</source><year>2016</year><volume>36</volume><fpage>2647</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.3892/or.2016.5111</pub-id><pub-id pub-id-type="pmid">27665945</pub-id></element-citation></ref><ref id="B119-cells-08-00091"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engl</surname><given-names>T.</given-names></name><name><surname>Rutz</surname><given-names>J.</given-names></name><name><surname>Maxeiner</surname><given-names>S.</given-names></name><name><surname>Juengel</surname><given-names>E.</given-names></name><name><surname>Roos</surname><given-names>F.</given-names></name><name><surname>Khoder</surname><given-names>W.</given-names></name><name><surname>Bechstein</surname><given-names>W.O.</given-names></name><name><surname>Nelson</surname><given-names>K.</given-names></name><name><surname>Tsaur</surname><given-names>I.</given-names></name><name><surname>Haferkamp</surname><given-names>A.</given-names></name><etal/></person-group><article-title>mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>16</volume><fpage>7064</fpage><lpage>7071</lpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7401</pub-id><pub-id pub-id-type="pmid">28901501</pub-id></element-citation></ref><ref id="B120-cells-08-00091"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.-O.</given-names></name><name><surname>Kim</surname><given-names>K.-H.</given-names></name><name><surname>Song</surname><given-names>I.S.</given-names></name><name><surname>Cheon</surname><given-names>K.-S.</given-names></name><name><surname>Kim</surname><given-names>O.-H.</given-names></name><name><surname>Lee</surname><given-names>S.C.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>S.-J.</given-names></name></person-group><article-title>Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>2936</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.13808</pub-id><pub-id pub-id-type="pmid">27935857</pub-id></element-citation></ref><ref id="B121-cells-08-00091"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name></person-group><article-title>Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2015</year><volume>456</volume><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.11.038</pub-id><pub-id pub-id-type="pmid">25446102</pub-id></element-citation></ref><ref id="B122-cells-08-00091"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.-Y.</given-names></name><name><surname>Tai</surname><given-names>W.-T.</given-names></name><name><surname>Hsieh</surname><given-names>C.-Y.</given-names></name><name><surname>Hsu</surname><given-names>W.-M.</given-names></name><name><surname>Lai</surname><given-names>Y.-J.</given-names></name><name><surname>Chen</surname><given-names>L.-J.</given-names></name><name><surname>Shiau</surname><given-names>C.-W.</given-names></name><name><surname>Chen</surname><given-names>K.-F.</given-names></name></person-group><article-title>A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3</article-title><source>Cancer Lett.</source><year>2014</year><volume>349</volume><fpage>136</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2014.04.006</pub-id><pub-id pub-id-type="pmid">24735751</pub-id></element-citation></ref><ref id="B123-cells-08-00091"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>W.-T.</given-names></name><name><surname>Shiau</surname><given-names>C.-W.</given-names></name><name><surname>Chen</surname><given-names>H.-L.</given-names></name><name><surname>Liu</surname><given-names>C.-Y.</given-names></name><name><surname>Lin</surname><given-names>C.-S.</given-names></name><name><surname>Cheng</surname><given-names>A.-L.</given-names></name><name><surname>Chen</surname><given-names>P.-J.</given-names></name><name><surname>Chen</surname><given-names>K.-F.</given-names></name></person-group><article-title>Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells</article-title><source>Cell Death Dis.</source><year>2013</year><volume>4</volume><fpage>e485</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.18</pub-id><pub-id pub-id-type="pmid">23392173</pub-id></element-citation></ref><ref id="B124-cells-08-00091"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name></person-group><article-title>Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy</article-title><source>Int. J. Mol. Med.</source><year>2013</year><volume>31</volume><fpage>1449</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2013.1351</pub-id><pub-id pub-id-type="pmid">23588698</pub-id></element-citation></ref><ref id="B125-cells-08-00091"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simioni</surname><given-names>C.</given-names></name><name><surname>Martelli</surname><given-names>A.M.</given-names></name><name><surname>Cani</surname><given-names>A.</given-names></name><name><surname>Cetin-Atalay</surname><given-names>R.</given-names></name><name><surname>McCubrey</surname><given-names>J.A.</given-names></name><name><surname>Capitani</surname><given-names>S.</given-names></name><name><surname>Neri</surname><given-names>L.M.</given-names></name></person-group><article-title>The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy</article-title><source>Oncotarget</source><year>2013</year><volume>4</volume><fpage>1496</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.1236</pub-id><pub-id pub-id-type="pmid">24036604</pub-id></element-citation></ref><ref id="B126-cells-08-00091"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>G.G.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Chun</surname><given-names>S.</given-names></name><name><surname>Leung</surname><given-names>B.C.S.</given-names></name><name><surname>Lai</surname><given-names>P.B.S.</given-names></name></person-group><article-title>Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK</article-title><source>Apoptosis</source><year>2012</year><volume>17</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1007/s10495-011-0685-y</pub-id><pub-id pub-id-type="pmid">22170404</pub-id></element-citation></ref><ref id="B127-cells-08-00091"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>R.</given-names></name><name><surname>Refolo</surname><given-names>M.G.</given-names></name><name><surname>Lippolis</surname><given-names>C.</given-names></name><name><surname>Messa</surname><given-names>C.</given-names></name><name><surname>Cavallini</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>R.</given-names></name><name><surname>Resta</surname><given-names>L.</given-names></name><name><surname>Di Carlo</surname><given-names>A.</given-names></name><name><surname>Carr</surname><given-names>B.I.</given-names></name></person-group><article-title>Reversibility of regorafenib effects in hepatocellular carcinoma cells</article-title><source>Cancer Chemother. Pharmacol.</source><year>2013</year><volume>72</volume><fpage>869</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1007/s00280-013-2269-8</pub-id><pub-id pub-id-type="pmid">23959464</pub-id></element-citation></ref><ref id="B128-cells-08-00091"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.C.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Tai</surname><given-names>W.T.</given-names></name><name><surname>Liu</surname><given-names>C.Y.</given-names></name><name><surname>Shiau</surname><given-names>C.W.</given-names></name><name><surname>Chen</surname><given-names>K.F.</given-names></name></person-group><article-title>Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>18249</fpage><lpage>18259</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.446385</pub-id><pub-id pub-id-type="pmid">23677989</pub-id></element-citation></ref><ref id="B129-cells-08-00091"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lewin</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Lian</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name></person-group><article-title>HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway</article-title><source>Free Radic. Biol. Med.</source><year>2014</year><volume>70</volume><fpage>194</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.02.012</pub-id><pub-id pub-id-type="pmid">24576507</pub-id></element-citation></ref><ref id="B130-cells-08-00091"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Yeh</surname><given-names>P.Y.</given-names></name><name><surname>Lu</surname><given-names>Y.S.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Chen</surname><given-names>K.F.</given-names></name><name><surname>Lee</surname><given-names>W.C.</given-names></name><name><surname>Feng</surname><given-names>W.C.</given-names></name><name><surname>Chen</surname><given-names>C.S.</given-names></name><name><surname>Kuo</surname><given-names>M.L.</given-names></name><name><surname>Cheng</surname><given-names>A.L.</given-names></name></person-group><article-title>OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>9348</fpage><lpage>9357</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1642</pub-id><pub-id pub-id-type="pmid">19010909</pub-id></element-citation></ref><ref id="B131-cells-08-00091"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeki</surname><given-names>I.</given-names></name><name><surname>Terai</surname><given-names>S.</given-names></name><name><surname>Fujisawa</surname><given-names>K.</given-names></name><name><surname>Takami</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><name><surname>Hirose</surname><given-names>Y.</given-names></name><name><surname>Murata</surname><given-names>Y.</given-names></name><name><surname>Yamasaki</surname><given-names>T.</given-names></name><name><surname>Sakaida</surname><given-names>I.</given-names></name></person-group><article-title>Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis</article-title><source>J. Gastroenterol.</source><year>2013</year><volume>48</volume><fpage>738</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1007/s00535-012-0675-z</pub-id><pub-id pub-id-type="pmid">23011081</pub-id></element-citation></ref><ref id="B132-cells-08-00091"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Seewoo</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Qiu</surname><given-names>W.</given-names></name></person-group><article-title>Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells</article-title><source>Oncol. Rep.</source><year>2012</year><volume>27</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">21935576</pub-id></element-citation></ref><ref id="B133-cells-08-00091"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.H.</given-names></name><name><surname>Loong</surname><given-names>C.C.</given-names></name><name><surname>Su</surname><given-names>T.L.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Chu</surname><given-names>P.M.</given-names></name><name><surname>Tsai</surname><given-names>M.L.</given-names></name><name><surname>Tsai</surname><given-names>P.H.</given-names></name><name><surname>Tu</surname><given-names>P.H.</given-names></name><name><surname>Chi</surname><given-names>C.W.</given-names></name><name><surname>Lee</surname><given-names>H.C.</given-names></name><etal/></person-group><article-title>Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway</article-title><source>Biochem. Pharmacol.</source><year>2011</year><volume>81</volume><fpage>594</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2010.12.011</pub-id><pub-id pub-id-type="pmid">21184746</pub-id></element-citation></ref><ref id="B134-cells-08-00091"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y.J.</given-names></name><name><surname>Dong</surname><given-names>L.W.</given-names></name><name><surname>Tan</surname><given-names>Y.X.</given-names></name><name><surname>Yang</surname><given-names>G.Z.</given-names></name><name><surname>Pan</surname><given-names>Y.F.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>H.Y.</given-names></name></person-group><article-title>Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma</article-title><source>Lab. Invest.</source><year>2011</year><volume>91</volume><fpage>1146</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2011.97</pub-id><pub-id pub-id-type="pmid">21647092</pub-id></element-citation></ref><ref id="B135-cells-08-00091"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>L.-W.</given-names></name><name><surname>Wang</surname><given-names>R.-X.</given-names></name><name><surname>Zheng</surname><given-names>X.-L.</given-names></name><name><surname>Feng</surname><given-names>X.-Q.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.-P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition</article-title><source>Oncol. Lett.</source><year>2017</year><volume>13</volume><fpage>5028</fpage><lpage>5034</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.6059</pub-id><pub-id pub-id-type="pmid">28599504</pub-id></element-citation></ref><ref id="B136-cells-08-00091"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Barr</surname><given-names>M.P.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>37052</fpage><pub-id pub-id-type="doi">10.1038/srep37052</pub-id><pub-id pub-id-type="pmid">27845389</pub-id></element-citation></ref><ref id="B137-cells-08-00091"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoen</surname><given-names>L.F.R.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>E.L.M.</given-names></name><name><surname>Doll&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Mannaerts</surname><given-names>I.</given-names></name><name><surname>Najimi</surname><given-names>M.</given-names></name><name><surname>Sokal</surname><given-names>E.</given-names></name><name><surname>van Grunsven</surname><given-names>L.A.</given-names></name></person-group><article-title>A role for autophagy during hepatic stellate cell activation</article-title><source>J. Hepatol.</source><year>2011</year><volume>55</volume><fpage>1353</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2011.07.010</pub-id><pub-id pub-id-type="pmid">21803012</pub-id></element-citation></ref><ref id="B138-cells-08-00091"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg-Lerner</surname><given-names>A.</given-names></name><name><surname>Bialik</surname><given-names>S.</given-names></name><name><surname>Simon</surname><given-names>H.-U.</given-names></name><name><surname>Kimchi</surname><given-names>A.</given-names></name></person-group><article-title>Life and death partners: Apoptosis, autophagy and the cross-talk between them</article-title><source>Cell Death Differ.</source><year>2009</year><volume>16</volume><fpage>966</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.33</pub-id><pub-id pub-id-type="pmid">19325568</pub-id></element-citation></ref><ref id="B139-cells-08-00091"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>L.A.</given-names></name><name><surname>Tavallai</surname><given-names>S.</given-names></name><name><surname>Hamed</surname><given-names>H.A.</given-names></name><name><surname>Cruickshanks</surname><given-names>N.</given-names></name><name><surname>Dent</surname><given-names>P.</given-names></name></person-group><article-title>The role of cell signalling in the crosstalk between autophagy and apoptosis</article-title><source>Cell. Signal.</source><year>2014</year><volume>26</volume><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.11.028</pub-id><pub-id pub-id-type="pmid">24308968</pub-id></element-citation></ref><ref id="B140-cells-08-00091"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlane</surname><given-names>S.</given-names></name><name><surname>Nicholl</surname><given-names>M.J.</given-names></name><name><surname>Sutherland</surname><given-names>J.S.</given-names></name><name><surname>Preston</surname><given-names>C.M.</given-names></name></person-group><article-title>Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha</article-title><source>Virology</source><year>2011</year><volume>414</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2011.03.005</pub-id><pub-id pub-id-type="pmid">21481907</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="cells-08-00091-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic diagram illustrating the proposed role of autophagy during the development of hepatocellular carcinoma.</p></caption><graphic xlink:href="cells-08-00091-g001"/></fig><table-wrap id="cells-08-00091-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">cells-08-00091-t001_Table 1</object-id><label>Table 1</label><caption><p>Therapeutic reagents modulating autophagy in anti-HCC treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reagents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Autophagy Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cells Treated</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Result</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sirolimus (Rapamycin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-cells-08-00091" ref-type="bibr">117</xref>,<xref rid="B118-cells-08-00091" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temsirolimus (CCI-779)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2, Huh7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-cells-08-00091" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Everolimus (RAD001)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hep3B, HepG2, Huh7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-cells-08-00091" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pemetrexed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mTORC1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B121-cells-08-00091" ref-type="bibr">121</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SC-59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mTORC1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLC5, Sk-Hep1, HepG2 and Hep3B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-cells-08-00091" ref-type="bibr">122</xref>,<xref rid="B123-cells-08-00091" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BEZ235</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI3K/mTOR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hep3B, PLC/PRF/5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-cells-08-00091" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MK-2206</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AKT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNU449, SNU378, SNU475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-cells-08-00091" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SB203580</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2, Hep3B, PLC/PRF/5, Huh-7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-cells-08-00091" ref-type="bibr">126</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regorafenib</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tyrosine-kinase inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2 and Hep3B </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-cells-08-00091" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sorafenib</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tyrosine-kinase inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hep3B, HepG2, Huh7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-cells-08-00091" ref-type="bibr">105</xref>,<xref rid="B112-cells-08-00091" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nilotinib</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tyrosine kinase inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLC5, Huh-7, Hep3B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-cells-08-00091" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABT-737</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">JNK pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh7, HepG2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B129-cells-08-00091" ref-type="bibr">129</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OSU-03012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PDK1/AKT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh7, Hep3B, and HepG2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B130-cells-08-00091" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-FU</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induce ER stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2, SMMC-7721, Hep3B, BEL-7402 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell survival</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-cells-08-00091" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bortezomib</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proteasome inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh7, HepG2, HuH7, human hepatocytes, rat hepatocytes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Upregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-cells-08-00091" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroquine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lysosome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG2, Huh7, HA22T/VGH, Mahlavu</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-cells-08-00091" ref-type="bibr">132</xref>,<xref rid="B133-cells-08-00091" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-MA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI3K III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H22, HepG2, PLC/PRF/5, SMMC7721</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of autophagy-cell death and cell survival </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B134-cells-08-00091" ref-type="bibr">134</xref>,<xref rid="B135-cells-08-00091" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bafilomycin A1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lysosome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BEL7402, HepG2, Huh7, SMMC-7721</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of autophagy-cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-cells-08-00091" ref-type="bibr">136</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>